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Overview 
 
 Part one of this major research project is a systematic review of the evidence 
for cognitive remediation for adults with substance use disorders (SUDs). Given the 
clinical heterogeneity across the 15 included studies (in terms of intervention 
characteristics, outcome measures used, and quality of reporting), a narrative approach 
was used to synthesize results. Although there was some evidence for the intervention 
improving some cognitive and substance use outcomes, this was not consistent, and 
the review highlights the lack of robust evidence for cognitive remediation for adults 
with SUDs. Suggestions for future research are discussed. 
 Part two is an empirical paper describing a study to assess the effects of 
frequent cannabis use on prospective memory. Prospective memory was assessed 
using the Virtual Week task over three groups: dependent cannabis users, non-
dependent cannabis users and non-using controls. There were no differences found 
between groups. The introduction of an imagining technique whereby participants had 
to imagine performing their prospective memory tasks during encoding did not 
improve prospective memory performance for any of the groups. The results raise 
important questions about the cognitive effects of cannabis use, and interpreting the 
findings of this study in light of the strengths and limitations of the research.  
 Part three is a reflection and critical appraisal on the major research project 
process as a whole, addressing some of the factors that led to the smooth running of 
the project, as well as some of the more challenging aspects that arose.  
 It is important to note that this was a joint research project with Samantha 
Mansell.  
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Abstract 
 
Background. Chronic substance use is associated with cognitive deficits that are 
predictive of poor clinical outcomes, such as drug relapse. Cognitive training 
interventions aim to remediate these cognitive deficits. Objectives. To assess whether 
cognitive remediation interventions for individuals with substance use disorders 
(SUDs) improve cognitive function and/or impact on treatment outcomes. Search 
Methods. Searches were undertaken of PsycINFO, MEDLINE and EMBASE, as well 
as reference lists of primary studies and review articles identified. Searches were done 
in November 2016. Selection Criteria. i) Randomised controlled trials (RCTs) 
comparing any cognitive remediation intervention to treatment-as-usual or a control 
group, ii) studies with adults meeting diagnostic criteria for a SUD or undergoing 
treatment for substance use, and iii) at least one cognitive, treatment or drug use 
outcome measure. Published trials only were included. Study Appraisal and 
Synthesis. Data was narratively (rather than meta-analytically) synthesised given the 
variability in interventions, outcomes and quality of reporting. Studies were rated for 
risk of bias using the Cochrane Risk of Bias tool.  Results. Fifteen RCTs were 
identified, including 1355 adults (10 trials on alcohol-dependent patients and five on 
patients in treatment for other substances). Although some trials had favourable effects 
for remediation groups on some cognitive and substance use outcomes, these were not 
consistent. The heterogeneity and bias in the studies and the review limit any 
inferences that can be drawn. Conclusions. At present, there is no conclusive evidence 
that cognitive remediation should be indicated as an adjunct to addiction treatment.  
Further research may be warranted, and recommendations regarding the design of 
future studies is given.    
12 
 
Introduction 
 
Substance use disorders (SUDs) are a global health concern. An estimated 240 
million people (4.9% of the world’s adult population) have an alcohol use disorder 
(Gowing et al., 2015), and between 16 and 39 million people have other SUDs (United 
Nations Office on Drugs and Crime, 2014). In addition to the well-known physical, 
psychological and social effects of SUDs, long-term drug and alcohol use has also 
been associated with deficits across a number of cognitive domains, including 
decision-making, response inhibition, planning, working memory, and attention 
(Rezapour, DeVito, Sofuoglu & Ekhtiari, 2016; Sofuoglu, DeVito, Waters, & Carroll, 
2013).  
Neurocognitive models of addiction highlight how ‘top-down’ cognitive 
deficits (i.e. deficits in processing information that has already been brought into the 
brain by one or more of the sensory systems) impacts the cycle of addiction, 
maintaining problematic substance use and poor treatment prognosis. For example, the 
Impaired Response Inhibition and Salience Attribution framework (Goldstein & 
Volkow, 2002) considers addictive disorders to arise from a top-down impairment of 
cognitive and motivational functions implicated in tracking, updating and modulating 
the salience of reinforcers, and in the ability to inhibit pre-potent responses. Thus, 
impairments in executive cognitive function may partially account for individuals’ 
problematic tendency to continue to use substances despite the negative consequences. 
Within these models, there is a distinction between the two interacting mechanisms: 
automatic ‘bottom-up’ stimulus-driven processes (e.g. triggered by drug cues), and 
controlled or executive top-down cognitive processes (e.g., linked to working memory 
and inhibition). 
13 
 
Models of addiction that implicate dysregulation of top-down processes are 
generally supported by cognitive and neuroimaging evidence (Littel, Euser, Munafo 
& Franken, 2012). In addition, the severity of cognitive deficits has been associated 
with the duration and amount of drug use, suggesting a causal link between drug use 
and neurocognitive deficits (Bolla, Brown, Eldreth, Tate & Cadet, 2002; Bolla, 
Rothman & Cadet, 1999). Some evidence also suggests deficits could be pre-existing 
(Ersche et al., 2012). In recent studies using the Montreal Cognitive Assessment 
(MoCA), cognitive impairment was detected in 68% and 73% of alcohol-dependent 
patients and 77% of drug-dependent patients following detoxification (Alarcon, 
Nalpas, Pelletier & Perney, 2015; Manning, Teo, Guo, Wong & Li, 2016), with 
consistent findings of the poorest performance in visuospatial processing, attention, 
memory and executive functioning.  
Cognitive deficits may interfere with addiction treatment by reducing the 
ability of the patient to encode, consolidate, integrate and employ information in the 
treatment sessions as well as their everyday lives (Fals-Stewart & Lam, 2010). 
Associations of moderate effect size have been found between general cognition and 
substance use treatment adherence, reward-based decision making, and alcohol and 
drug relapse (Dominguez-Salas, Díaz-Batanero & Verdejo-García, 2016), further 
supporting the idea that deficits in cognitive functioning could be a contributing factor 
to the maintenance of SUDs.  
Despite this, cognitive deficits are not generally targeted by addiction 
treatments. The most common psychosocial interventions available in the NHS in 
England specifically target drug-use behaviours, and include: Motivational 
Interviewing (Miller & Rollnick, 2012), relapse prevention (Marlatt & Gordon, 1985), 
and humanistic and 12-step approaches (NICE, 2007). It is plausible that cognitive 
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training as an adjunct to treatment may provide a cognitive ‘strengthening’ to patients 
with cognitive impairments, which may in turn enable them to adhere to treatment 
more effectively.  
Broadly classified as ‘cognitive remediation’ (also known as ‘cognitive 
training’, ‘cognitive re-training’ or ‘cognitive rehabilitation’), interventions typically 
involve repeated practise or strategy training on cognitive exercises which aim to 
improve or restore functioning within a specific cognitive domain or across multiple 
domains. Such interventions tend to target executive or controlled cognitive processes, 
such as working memory or attention, and a distinction can be made between these 
and other interventions which target bottom-up automatic cognitive mechanisms (e.g. 
Cognitive Bias Modification; Wiers, Gladwine, Hofmann, Salemink, & Ridderinkhof, 
2013).  
Although remediating cognitive deficits through cognitive training makes 
theoretical sense, it is important to address the effectiveness of such interventions 
through systematically identifying, appraising and synthesizing the existing research. 
Evidence for cognitive remediation in other disorders is limited. For example, there 
are inconclusive findings reported in Cochrane systematic reviews of cognitive 
remediation for dementia (Bahar-Fuchs, Clare, & Woods, 2003), stroke (das Nair, 
Cogger, Worthington & Lincoln, 2016) and schizophrenia (McGrath & Hayes, 2000).  
 
Previous Reviews  
Searches indicate that there are no systematic reviews on cognitive remediation 
for SUDs. Several narrative articles exist reviewing the emerging literature and 
neuropsychological mechanisms, including cognitive remediation for alcohol 
addiction (Allen, Goldstein & Seaton, 1997; Bates, Buckman & Nguyen, 2013) and 
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across drug and alcohol addiction (Campanella, 2016; Rezapour et al., 2016; Sofuoglu 
et al., 2016; Verdejo-Garcia, 2016; Manning, Verdejo-Garcia & Lubman, 2017; Vocci, 
2008). However, these reviews do not set minimum quality criteria for study design or 
specify their search strategy, and are therefore at risk of selection bias.  
 
Implications 
By collating the existing research and rating the quality of the evidence, the 
review may have implications for future research. It is also hoped that inferences will 
be drawn on the effectiveness of cognitive interventions for obviating cognitive 
deficits, which may have implications for the content of addiction treatment 
programmes.  
 
Objectives of the Review  
Building upon neuropsychological models of addiction and existing narrative 
reviews, the objective of this systematic review is to answer the following question: 
do cognitive remediation interventions for SUDs remediate cognitive deficits and/or 
impact upon treatment outcomes?  
 
Method 
 
Eligibility Criteria 
Studies were assessed for inclusion in terms of the research design, population 
characteristics, intervention, outcome measures used and publication status.  
 
Research Design 
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Included studies were randomised controlled trials (RCTs) or cluster-
randomised trials that randomised to an experimental and control/comparison group. 
Non-randomised or quasi-randomised trials were excluded due to the increased risk of 
bias.  
 
Population 
Included studies were required to have: (i) an adult sample, and (ii) participants 
who met criteria (e.g. DSM-III, DSM-IV or ICD-10) for a diagnosis of a substance use 
disorder (SUD), dependency, or addiction on a substance excluding nicotine, or who 
were undergoing treatment for substance use. Studies were excluded if participants 
had a psychotic disorder, traumatic brain damage, a neurological impairment or a 
learning disability.  
 
Intervention 
Studies were included that assessed any cognitive remediation intervention that 
directly or indirectly targeted top-down cognitive functioning. Interventions could be 
delivered in any format (e.g. pen-and-paper or computerised). The comparison 
group(s) of included studies could be treatment-as-usual or an alternative intervention.  
 
Outcomes 
Primary outcomes were measures of cognition, treatment outcomes, and 
substance use. To be included in the review, studies must have included at least one 
cognitive, treatment or substance use outcome measure.   
 
Publication 
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Studies were restricted to published full-text journal articles written in English. 
No date limits were set.  
 
Search Methods 
Papers were identified through a search of three electronic databases: 
MEDLINE (1946 to November 2016), EMBASE (1980 to November 2016) and 
PsycINFO (1806 to November 2016), using the Ovid interface in November 2016. The 
search terms used, including key words and synonyms, were: ‘cognitive remediation’, 
‘substance use’ and ‘relapse prevention’. The first two terms were selected to capture 
the intervention and population. ‘Relapse prevention’ was added to the search string 
to identify studies that may have offered a cognitive training intervention as part of a 
relapse prevention programme. The full search terms are listed in Appendix 1.  
 
Study Quality 
The methodological quality of the studies was assessed using the criteria 
outlined in the Cochrane Handbook for Systematic Reviews of Interventions (Higgins 
et al., 2011). The risk of bias was assessed in the following domains: random sequence 
generation, allocation concealment, blinding of participants and personnel, blinding of 
outcome assessment, incomplete outcome data and attrition, selective outcome 
reporting, and other biases. A second reviewer SM (my research project partner) 
independently assessed the risk of bias for each study, and any disagreements were 
resvolved by discussion or consulting our research supervisors for a third opinion.   
Each potential source of bias was graded as ‘high’, ‘low’ or ‘unclear’. A quote 
from the study paper or justification for the judgement is given for each bias domain, 
and presented in a risk of bias table for each study (see Appendix 2). Where risk of 
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bias judgments were ‘unclear’, the study authors were emailed if their contact details 
were provided in the papers, and any responses received were recorded. 
 
Analyses 
Given the clinical heterogeneity in the studies, including differences in the 
components and implementation of the interventions and comparisons, the outcome 
measures used, and quality of reporting, the results are discussed narratively rather 
than combined statistically with meta-analyses.  
 
Results 
 
Results of the Search 
After duplicates had been removed, a total of 3874 citations were identified. 
All titles and abstracts were screened. Forty-five full-text articles were retrieved; 13 of 
these met the inclusion criteria and 32 articles were excluded. To ensure that all 
relevant articles were included, existing literature reviews and reference lists from 
included papers were examined and screened against the inclusion criteria. Two more 
articles were identified. This resulted in a total of 15 studies being included in the 
review (Figure 1). 
 
Included Studies 
Fifteen studies (n = 1355) met the inclusion criteria for the review. Fourteen 
studies were RCTs and one study a cluster-randomised controlled trial (Czuchry & 
Dansereau, 2003). Studies were published between 1987 and 2016, and ranged in  
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Figure 1. Study Flow Diagram 
 
 
population size from eight to 450 (median: 66). Three studies were conducted in 
Europe (Gamito et al., 2014; Rupp, Kurz, Hinterhuber & Fleischhacker, 2012; 
Steingass, Bobring, Burgart, Sartory & Schugens, 1994), 11 in North America (Bell, 
Vissicchio & Weinstein, 2016; Czuchry & Dansereau, 2003; Fals-Stewart & Lucente, 
1994; Fals-Stewart & Lam, 2010; Goldman & Goldman, 1987; Grohman & Fals-
Stewart, 2003; Rass et al., 2015; Roehrich & Goldman, 1993; Stringer & Goldman, 
1998; Wetzig & Hardin, 1990; Yohman, Schaeffer & Parsons, 1988), and one in India 
(Mathai, Rao & Gopinath, 1998).  
Tables 1 and 2 display the study characteristics and main findings.  Given the 
large proportion of studies testing samples in treatment for alcohol use, the studies are 
presented according to alcohol studies (Table 1) and other substances (Table 2). Effect 
Articles retrieved and abstracts 
reviewed = 3874 
Excluded articles = 3829 
Full-text articles reviewed = 45 Excluded articles = 32, with 
reasons: 
6 not in English 
3 nature of population  
4 not CR intervention 
5 not an RCT 
14 review articles 
Articles included from search 
results = 13 
Articles in review = 15 
Articles included from 
reviews and reference lists 
= 2 
20 
 
sizes (Cohen’s d or partial eta-squared ηp2) were rarely reported, but appear in Table 1 
and 2 if available. There was wide variation in statistical procedures used and in the 
quality of reporting. Therefore, the statistics for the main findings are not presented.
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Table 1. Included Studies - Alcohol 
Study 
and 
Country 
N Populationa 
Clinical 
Diagnosis 
Groups 
(N Starters/ 
Completers) 
Description of 
Interventions/ 
Comparators 
Length 
Cognitive 
Target(s) 
Outcome 
Measuresb 
Main 
Findings 
Bell et al. 
(2016); 
USA 
34 Outpatients 
 
97% male 
 
55.2 years 
(SD = 1.7) 
Alcohol-use 
Disorders 
(MINI) 
CCT (16/15) 
 
WT (18/16) 
Active:  
Computerised 
cognitive 
training (Brain 
Fitness & 
InSight) plus 
work therapy & 
TAU  
 
Control: Work 
therapy only & 
TAU 
13 weeks 
(CCT for 
M =41.2 
hours, 
plus work 
therapy M 
= 190.9 
hours; WT 
only, M = 
252.9 
hours) 
 
Auditory & 
visual: learning, 
attention and 
memory (e.g. 
elementary 
sensory 
processing 
tasks, to 
increasing 
memory-load 
story recall 
tasks) 
3 
 
PT, FU  
(3 months) 
 
 
PT significant 
effect of 
condition on 
verbal learning 
& memory 
score, 
sustained at 3-
month FU 
Gamito et 
al. 
(2014); 
Portugal 
68 NR 
 
80% male 
 
45.4 years 
(SD = 10.1) 
 
Alcohol 
Dependence 
(DSM-IV) 
 CS (33/26) 
 
TAU (35/28) 
Active: 
mHealth 
(mobile health) 
serious-games 
based cognitive 
stimulation 
programme 
with mobile 
technology  
 
Control: TAU 
 
 
10 60-
minute 
sessions 
over 4-6 
weeks 
Executive 
functioning: 
attention (e.g. 
slot machine 
task), working 
memory (e.g. 
visual memory 
task) & logical 
reasoning (e.g. 
word-object 
correspondence) 
    
36, 40, 50, 
58 
 
PT 
No effect of 
group on 
MMSE or 
cognitive 
flexibility, 
processing 
speed or 
attention. CS 
group had 
significant 
increase in 
FAB scores, 
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whereas TAU 
group did not 
 
Goldman 
& 
Goldman 
(1987); 
USA 
66 Inpatients   
 
100% male 
 
<40 years 
 
 
 
Alcohol 
Dependence  
(DSM-III)  
CRT1 
(NR/NR) 
 
CRT2 
(NR/NR) 
 
TAU1 
(NR/NR) 
 
TAU2 
(NR/NR) 
 
CG (13/NR) 
 
 
Active groups: 
2 cognitive 
remediation 
groups 
(different sites) 
received 2 
sessions of 
training of 3 
visuospatial 
tasks 
 
Control groups: 
2 TAU groups 
(different sites) 
& an non-
alcoholic 
control group 
(no 
remediation) 
 
2 45-
minute 
sessions 
Visuospatial 
processing 
(training on the 
component parts 
of Trails B: 
visual scanning 
speed & 
accuracy, verbal 
series 
alternation, 
integration of 
scanning & 
symbol 
manipulation)  
39 
 
PT 
The 2 
remediated 
alcoholic 
groups 
performed 
similarly to the 
matched, non-
alcoholic 
controls on 
Trails B, while 
non-
remediated 
alcoholic 
groups were 
worse than 
normal at both 
time lags 
Mathai et 
al. 
(1998); 
India 
8 Inpatients  
 
100% male 
 
40.0 years 
(SD = 5.5)  
Alcohol 
Dependence 
(ICD-9) 
CT (4/4) 
 
TAU (4/3) 
Active: 
Cognitive 
training of 
various tasks, 
increasing in 
difficulty levels 
 
Control: TAU 
 
 
Daily for 
1-hour 
over 6 
weeks 
Attention, 
memory (verbal 
& visual), 
information 
processing, & 
executive 
function 
1, 23, 26, 
27, 29, 48, 
73 
 
PT, FU  
(1 month) 
Significant 
improvement 
PT in CT 
group in 3/14 
tests; serial 
processing, 
memory & 
number of 
neuro-
psychological 
deficits.  
23 
 
2 of the 
patients in the 
CT group were 
abstinent at 
1month FU 
whilst 2 had 
relapsed 
 
Roehrich 
& 
Goldman 
(1993); 
USA 
80 Inpatients 
 
100% male 
 
42.5 years 
(SD = 10.8) 
 
Alcohol 
Dependence 
(DSM-III-R) 
NEURO-
REM (15/15) 
 
ECO-REM 
(15/15) 
 
PBO-REM 
(16/16) 
 
CG (15/15) 
Active groups: 
Standard 
neuropsycholog
ical remediation 
group received 
self-guided 
workbooks 
(NEURO-
REM), & an 
  ecologically 
relevant 
remediation 
group who also 
were given self-
guided 
workbooks 
(ECO-REM) 
 
Control groups: 
Attention 
placebo tasks 
group, & a no 
remediation 
control group  
 
 
4 1hr 
sessions, 
over 3 
weeks 
NEURO-REM: 
Visual scanning, 
visuospatial 
skills, 
psychomotor 
speed, cognitive 
flexibility, & 
problem solving 
 
ECO-REM: 
attention, 
reasoning, & 
problem solving 
23, 38, 68 
 
PT 
Both 
remediation 
groups showed 
more 
improvement 
for each 
experience-
dependent 
measure than 
the PBO-REM 
& control 
groups. 
Transfer 
effects to RP 
measures 
significantly 
better scores 
for 
remediation 
groups 
compared to 
control groups, 
with a slight 
advantage for 
standard 
neuro-
psychological 
24 
 
stimulation 
procedures 
  
Rupp et 
al. 
(2012); 
Austria 
41 Inpatients 
with mild 
impairment 
on baseline 
task 
 
63.4% male 
 
45.4 years 
(SD = 9.7) 
 
Alcohol 
dependence 
(DSM-IV) 
CRT (20/ 
20) 
 
TAU (21/17) 
Active: 
Computer-
assisted 
cognitive 
remediation 
(Cogpack), 
trained over 62 
exercises  
 
Control: TAU 
 
 
12 45-60 
minute 
sessions, 
over 4 
weeks 
Attention, 
executive 
function & 
memory  
2, 10, 13, 
18, 25, 30, 
32, 38, 39,  
51, 52, 53, 
54, 58, 72 
 
PT 
Improvements 
in alertness 
(ηp2=0.1), 
divided 
attention 
(ηp2=0.1), 
working 
memory 
(ηp2=0.1) & 
delayed 
memory 
(ηp2=0.12) for 
CRT group 
(medium range 
effect sizes), 
but not 
inhibition and 
several other 
cognitive 
measures  
 
Steingass 
et al. 
(1994); 
Germany 
29 Inpatients 
 
82.8% male 
 
52.5 years 
(SD = 8.1) 
NR AMT 
(14/NR) 
 
WL (15/NR) 
Active: 
Cognitive 
training 
sessions, 
memory games 
& scanning 
tasks in a small 
group (up to 10 
people) 
 
Twice per 
week of 
training, 
once per 
week of 
games, for 
6 weeks 
Attention and 
memory; 12 
tasks and 
several games 
(e.g. picture 
recall, face-
name 
associations, 
learning details 
of group 
members)  
5, 11, 12, 
17, 19, 20, 
28, 37, 55 
 
PT 
Memory 
training group 
had improved 
performance in 
verbal memory 
tests & 
reproduction 
of drawings, 
but not on 
other measures 
25 
 
Control: 
Waiting-list 
control 
 
 
Stringer 
& 
Goldman 
(1998); 
USA 
40 Inpatients 
with baseline 
scores within 
one SD of the 
mean of their 
age 
 
100% male 
 
 >40 years  
DSM-III 
Alcohol 
Dependence 
CRG1 
(NR/NR) 
 
CRG2 
(NR/NR) 
 
TAU1 
(NR/NR) 
 
TAU2 
(NR/NR) 
 
CG (NR/NR) 
Active groups: 
One group 
taught a strategy 
for constructing 
block designs 
and given 
guided practice 
(CRG1) & one 
group given 
practice but 
without training 
(CRG2) 
 
Control groups: 
pre- and post-
testing only 
(TAU1), post-
test only 
(TAU2) & non-
alcoholic 
controls (CG) 
 
2 30-
minute 
remediatio
n sessions 
Visuospatial 
perception & 
problem solving 
 
 
53 
 
PT 
Remediated 
groups 
improved 
significantly 
compared to 
the control 
group  
No difference 
between the 
two 
remediation 
groups: in 
supplemented 
strategy 
training & 
simple practice  
Wetzig & 
Hardin 
(1990); 
USA 
45 Inpatients 
with 
impairment at 
baseline  
 
100% male 
 
34.8 years 
(SD = 11.1) 
NR  EXP 
(15/NR) 
 
PRAC 
(15/NR) 
 
TAU 
(15/NR) 
Active: 
Training on a 
hierarchical 
cumulative 
learning 
programme on 
the Wisconsin 
Card Sorting 
Test (WCST) 
45-
minutes 
twice over 
two days 
Abstract 
reasoning & 
conceptual 
flexibility 
(shifting) 
50 
 
PT 
EXP group 
demonstrated 
significantly 
improved 
performance 
over the PRAC 
and TAU 
groups on the 
3 measures 
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a Treatment type, Percentage male, mean age. Where age (mean/SD) was reported per group, a formula was used to compute an average for whole sample. 
b Outcome measures are listed in Table 3. Outcome measures in bold are composite or cluster measures where individual outcomes were not reported. 
MT – Mid-treatment 
PT – Post-treatment 
FU – Follow up 
NR – Not reported 
TAU – Treatment-as-usual 
 
 
 
 
 
 
 
 
Control groups: 
practice only on 
WCST (PRAC) 
& a TAU group 
 
taken from the 
WCST 
Yohman 
et al. 
(1988); 
USA 
76 Inpatients 
 
100% male 
 
42.7 years 
(SD = 9.3) 
National 
Council on 
Alcoholism 
Criteria for 
Alcoholism 
MT (25/NR) 
 
PT (26/NR) 
 
TAU 
(25/NR) 
 
CT (36/NR) 
 
 
 
Active groups: 
Memory (MT) 
or problem 
solving training 
(PT), 
introducing 
specific 
techniques & 
provided guided 
& unguided 
practice 
 
Control groups: 
TAU, & a non-
alcoholic 
control group 
(no 
remediation) 
 
12 hours 
over 10 
daily 
sessions 
Memory (verbal 
& visual) and 
problem solving 
4, 5, 7, 11, 
14, 15, 23, 
39, 41, 42, 
43, 44, 48, 
52. 9, 46, 
56 
 
PT 
Problem 
solving group 
improved more 
on the problem 
solving cluster 
than did either 
of the other 
two groups   
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Table 2. Included Studies - Other Substances 
Study and 
Country 
N Populationa 
Clinical 
Diagnosis 
Groups 
(N Starters/ 
Completers) 
Description 
of 
intervention/ 
Comparators 
Length 
Cognitive 
Target(s) 
Outcome 
Measuresb 
Main Findings 
Czuchry & 
Dansereau 
(2003); 
USA 
452 Inpatient 
probationers 
 
69% male 
 
-- 
 
NR 
 
Mixed 
substances 
CSM 
(232/NR) 
 
TAU 
(220/NR) 
 
 
Active: The TCU 
Cognitive Skills 
Modules (CSM): 
10 self-study 
booklets covering 
‘critical skills’ 
 
Control: TAU 
 
5 weeks to 
complete 
10 
booklets. 
16.8 weeks 
of 
treatment, 
12.6 weeks 
of aftercare 
Memory, 
comprehensio
n, self-
regulation, 
goals setting 
& planning 
approaches 
64, 65, 66 
 
MT, PT 
CSM increased 
residents’ 
involvement in 
treatment including 
engagement, 
cooperation, 
respect for other 
residents. CSM 
more effective at 
MT than PT 
 
Fals-
Stewart & 
Lucente 
(1994); 
USA 
80 Inpatients 
mandated to 
treatment 
with general 
cognitive 
impairment 
 
-- 
 
29.3 years 
(SD = 6.0) 
 
 
NR 
 
Mixed 
substances 
CACR 
(20/18) 
 
PMRAC 
(20/18) 
 
CTAC 
(20/18) 
 
TAU 
(20/18) 
 
Active: 
Computer-
assisted cognitive 
rehabilitation (13 
tasks)  
 
Control groups: 
Progressive 
muscle relaxation 
(PMRAC), 
computer training 
control (CTAC) 
and a TAU group 
 
 
Twice 
weekly for 
50 minutes 
over 25.2 
weeks 
Attention, 
motor skills, 
spatial 
orientation & 
word memory 
23, 39, 47, 
53, 57, 60 
 
MT, PT 
CACR group, on 
average, received 
higher scores on 
the 
neuropsychological 
test battery across 
the measurement 
interval (0-6 
months) than the 
other conditions 
(η2=0.5). However, 
thfe CACR was not 
significantly 
different from 
control conditions 
at 6-months (PT) 
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on the 
neuropsychological 
battery 
 
Fals-
Stewart & 
Lam 
(2010); 
USA 
160 Inpatients  
 
59% male 
 
32.8 years 
(SD = 7.0) 
 
One or 
more 
Substance 
Use 
Disorders 
(DSM-IV) 
CACR 
(80/75) 
 
CATT 
(80/72) 
Active: 
Computer-
assisted cognitive 
rehabilitation 
(PSSCogReHab) 
 
Control: 
Computer-
assisted typing 
tutorial 
 
 
3 times 
weekly for 
50 minutes 
over 9 
weeks 
Visuospatial, 
complex 
attention, 
problem 
solving & 
memory 
59, 60, 61, 
62, 63, 67, 
69, 72 
 
PT, FU  
(3, 6, 9 12 
months) 
CACR had greater 
improvement in 
cognitive scores at 
PT. CACR had 
lower Addiction 
Severity Index 
scores & higher 
percentage of days 
abstinent at 12-
month FU 
 
Grohman & 
Fals-
Stewart 
(2003); 
USA 
120 Inpatient 
 
70.8% male 
 
32.2 years 
(SD = 5.2)  
Substance 
use 
disorders 
(DSM-IV) 
CACR 
(40/?) 
 
CATT 
(40/?) 
 
TAU 
(40/?) 
Active: 
Computer-
assisted cognitive 
rehabilitation 
(PSSCogReHab)- 
sequence of 13 
rehabilitation 
tasks 
 
Control groups: 
Computer-
assisted typing 
tutorial - trained 
to type through 
fixed sequence 
(CATT), & a 
TAU group 
 
3 times 
weekly for 
50 minutes 
over 8 
weeks 
Attention, 
motor skills, 
spatial 
orientation, & 
word memory 
63, 67 
 
PT 
CACR stayed in 
treatment longer 
than CATT & were 
more likely to 
leave due to 
‘graduation’ 
29 
 
Rass et al. 
(2015); 
USA 
56 Outpatients 
 
46.4% male 
 
43.4 years 
(SD = 8.0) 
NR 
Stable 
Methadone 
(opioid) 
CCRT 
(37/28) 
 
ACC 
(36/28) 
Active: 
Computerised 
cognitive 
remediation: 
(Cogmed QM)  
 
Control: Active 
computer control 
 
  
25 45-
minute 
sessions, 3-
5 times per 
week 
Working 
memory 
(verbal & 
visuospatial) 
6, 16, 19, 
20 21, 22, 
24, 31, 33, 
34, 35, 38, 
39, 45, 69, 
70, 71  
 
PT 
Some cognitive 
outcomes 
(including working 
memory tasks 
similar to the 
training) showed 
improved 
performance at PT. 
Drug use increased 
in ACC & 
remained constant 
in CCRT 
a Treatment type, Percentage male, mean age. Where age (mean/SD) was reported per group, a formula was used to compute an average for whole sample. 
b Outcome measures are listed in Table 3. Outcome measures in bold are composite or cluster measures where individual outcomes were not reported. 
MT – Mid-treatment 
PT – Post-treatment 
FU – Follow up 
NR – Not reported 
TAU – Treatment-as-usual 
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Participants 
All studies recruited participants with diagnosed SUDs (alcohol or other 
substances), or patients in treatment for a SUD. Two studies (Goldman & Goldman, 
1987; Stringer & Goldman, 1998) also included non-SUD control groups. Ten studies 
recruited patients in treatment for alcoholism (Bell et al., 2016; Gamito et al., 2014; 
Goldman & Goldman, 1987; Mathai et al., 1998; Roehrich & Goldman, 1993; Rupp 
et al., 2012; Steingass et al., 1994; Stringer & Goldman, 1998; Wetzig & Hardin, 1990; 
Yohman et al., 1988), four studies recruited patients with mixed substance use 
(Czuchry & Dansereau, 2003; Fals-Stewart & Lucente, 1994; Fals-Stewart & Lam, 
2010; Grohman & Fals-Stewart, 2003) and one study recruited patients on a stable 
dose of methadone for opioid addiction (Rass et al., 2015).  
All studies recruited participants through substance use treatment centres. 
Twelve studies recruited inpatients in residential treatment programmes (Czuchry & 
Dansereau, 2003; Fals-Stewart & Lucente, 1994; Fals-Stewart & Lam, 2010; Goldman 
& Goldman, 1987; Grohman & Fals-Stewart, 2003; Mathai et al., 1998; Roehrich & 
Goldman, 1993; Rupp et al., 2012; Steingass et al., 1994; Stringer & Goldman, 1998; 
Wetzig & Hardin, 1990; Yohman et al., 1988), and two studies recruited outpatients 
(Bell et al., 2016; Rass et al., 2015). One study did not report residential status of the 
treatment programme (Gamito et al., 2014).  
The mean age of the randomised populations ranged from 29.3 to 55.2. No 
studies mentioned recruiting adolescents under the age of 18. Most studies excluded 
patients with a history of epilepsy, head injury or neurological history unrelated to 
substance use.  
Four studies required participants to be impaired cognitively at baseline. One 
study (Rupp et al., 2012) had a requisite for at least a ‘mild’ impairment on one of the 
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cognitive tasks at baseline (one SD below the mean), another study (Stringer & 
Goldman, 1998) required WAIS-R vocabulary scores within one SD of the mean of 
their age, a third study (Wetzig & Hardin, 1990) required a baseline deficit in the 
Wisconsin Card Sorting Test ‘as per the profile of alcoholic performance’ and the 
fourth study (Fals-Stewart & Lucente, 1994) recruited only those displaying a general 
cognitive impairment defined as a T score less than 40 on a summary score of cognitive 
measures.  
 
Interventions  
The studies tested a variety of cognitive remediation interventions, varying in 
cognitive focus, delivery format and duration of the intervention.  
Twelve studies tested an intervention tapping a number of cognitive domains 
and skills (Bell et al., 2016; Czuchry & Dansereau, 2003; Fals-Stewart & Lucente, 
1994; Fals-Stewart & Lam, 2010; Gamito et al., 2014; Grohman & Fals-Stewart, 2003; 
Mathai et al., 1998; Rass et al., 2015; Roehrich & Goldman, 1993; Rupp et al., 2012; 
Steingass et al., 1994; Yohman et al., 1988), whereas the other three studies tested an 
intervention which involved guided or repeated practise of one task or a few very 
similar tasks (Goldman & Goldman, 1987; Stringer & Goldman, 1998; Wetzig & 
Hardin, 1990).  
Six studies tested interventions delivered via a computer programme (Bell et 
al., 2016; Fals-Stewart & Lucente, 1994; Fals-Stewart & Lam, 2010; Grohman & Fals-
Stewart, 2003; Rass et al., 2015; Rupp et al., 2012) and one study an intervention using 
mobile technology (Gamito et al., 2014). Five studies tested non-computerised 
interventions with relatively few details about the procedure and format (Goldman & 
Goldman, 1987; Mathai et al., 1998; Stringer & Goldman, 1998; Wetzig & Hardin, 
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1990; Yohman et al., 1988). Two studies administered self-study workbooks (Czuchry 
& Dansereau, 2003; Roehrich & Goldman, 1993), and one study delivered the 
intervention in group format to groups of up to 10 participants (Steingass et al., 1994).  
Of the studies which delivered a computerised intervention, four of these were 
proprietary: Brain Fitness and InSight (Bell et al., 2016), Cogpack (Rupp et al., 2012), 
PSSCogReHab (Fals-Stewart & Lam, 2010; Grohman & Fals-Stewart, 2003) and 
CogMed QM (Rass et al., 2015).  
Whereas most studies delivered the intervention over several weeks, three 
studies only offered two sessions of cognitive remediation (Goldman & Goldman, 
1987; Stringer & Goldman, 1998; Wetzig & Hardin, 1990) and one study four sessions 
(Roehrich & Goldman, 1993).  
 
Comparison Groups 
Of the eight studies with two arms, five compared the intervention to treatment-
as-usual (Bell et al., 2016; Czuchry & Dansereau, 2003; Gamito et al., 2014; Mathai 
et al., 1998; Rupp et al., 2012), two studies to a group that controlled for attention 
(Fals-Stewart & Lam, 2010; Rass et al., 2015) and one to a waiting-list control 
(Steingass et al., 1994).  
Seven studies had more than two arms; three studies had two cognitive 
remediation groups and treatment-as-usual, non-alcoholic control or attention-control 
comparator groups (Goldman & Goldman, 1987; Roehrich & Goldman, 1993; 
Yohman et al., 1988), two studies had practice-only groups in addition to intervention 
and treatment-as-usual groups (Stringer & Goldman, 1998; Wetzig & Hardin, 1990), 
and two studies compared intervention groups to attention-control and treatment-as-
usual groups (Fals-Stewart & Lucente, 1994; Grohman & Fals-Stewart, 2003).  
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Outcomes 
Eight studies measured cognitive outcomes only (Bell et al., 2016; Gamito et 
al., 2014; Goldman & Goldman, 1987; Mathai et al., 1998; Steingass et al., 1994; 
Stringer & Goldman, 1998; Wetzig & Hardin, 1990; Yohman et al., 1988). Cognitive 
outcomes either related to the domain of cognition targeted by the intervention or more 
general cognitive functioning, in order to determine generalisation beyond the trained 
domain. Two studies measured treatment outcomes only (Czuchry & Dansereau, 2003; 
Grohman & Fals-Stewart, 2003).  Five studies measured cognitive as well as treatment 
or substance use outcomes (Fals-Stewart & Lucente, 1994; Fals-Stewart & Lam, 2010; 
Rass et al., 2015; Roehrich & Goldman, 1993; Rupp et al., 2012). All assessments 
were undertaken post-intervention, and three studies measured outcomes at follow-up: 
one month (Mathai et al., 1998), three months (Bell et al., 2016), and up to 12 months 
(Fals-Stewart & Lam, 2010).  
There was considerable variation in outcome measures used. A total of 59 
different cognitive outcome measures (including composite scores), nine treatment 
outcomes and five substance use outcomes were reported over the studies. These have 
been broadly categorised under the subheadings in Table 3, which lists the outcome 
measures in full. The number key in Table 3 corresponds to the outcomes listed by 
study in Table 1 and Table 2.
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Table 3. Outcome Measures 
 
 
Declarative Memory 
 Learning and Recall 
1 Cued recall (Menon & Rao, 
1997) 
2 Munich Verbal Memory Test 
(Ilmberger, 1988) 
3 Hopkins Verbal Learning Test 
Revised (Benedict, Schretlen, 
Groninger, & Brandt, 1998) 
4 Luria Memory Words (Luria, 
1976) 
5 Weschler Memory Scale: 
Logical Memory (Wechsler & 
Strone, 1987) 
6 Word recall and recognition 
(Snodgrass & Corwin, 1988) 
7 Verbal Paired Associates 
(Yohman & Parsons, 1985) 
8 Weschler Memory Scale: 
Verbal paired associates 
learning (Wechsler & Stone, 
1987) 
9 ‘Learning and memory’ cluster 
score (Yohman et al., 1988) 
 
 Visuospatial Memory 
10 Complex Figure Test recall 
(Lezak et al., 2004) 
11 Weschler Memory Scale: 
Visual reproduction (Wechsler 
& Stone, 1987) 
12 Street-Map Test (Baumler, 
1974) 
 
 Working Memory 
 
13 Two-back paradigm in working 
memory subtest of the Test 
Battery on Attentional 
Performance (Zimmermann & 
Fimm, 1993) 
14 Symbol-Digit Paired 
Associates (Ryan & Butters, 
1980) 
15 Face-Name Paired Associates 
(Schaeffer & Parsons, 1987) 
  
  
  
16 Visuospatial Working Memory 
Task (Rapport et al., 2008) 
17 Categorised Verbal Memory 
Test (Channon, Daum & 
Polkey, 1989) 
18 Digit Span Forward and 
Backward from German 
WAIS-R (Tewes, 1994) 
19 Digit Span Forward (Weschler, 
1981) 
20 Digit Span Backward 
(Weschler, 1981) 
21 N-back Task (Jonides et al., 
1997) 
22 Operation Span: proportion of 
correctly recalled words 
(Turner & Engle, 1989) 
 
 Attention 
 
 Processing Speed/Simple 
Attention 
23 WAIS Digit Symbol 
(Weschler, 1981) 
24 Digit Symbol Substitution Task 
(McLeod, Griffiths, Bigelow & 
Yingling, 1982) 
25 Alertness Test, subtest of Test 
Battery on Attentional 
Performance (Zimmermann & 
Fimm, 1993) 
26 Simple and choice reaction 
time (Mathai et al., 1998) 
 
 Sustained Attention 
27 Figure Identification task 
(Weintraub & Mesulam, 1988) 
28 D2-Test (Brickenkamp, 1962) 
 
 Divided Attention 
29 Triads Task and Rhythm 
Detection Task (Misra & Raso, 
1994) 
30 The Divided Attention Test, 
subtest of Test Battery on 
Attentional Performance 
(Zimmermann & Fimm, 1993) 
 
35 
 
 Executive Function 
 
 Inhibition and Impulsivity 
31 A Continuous Performance 
Task (Epstein et al., 1998) 
32 Incompatibility test (spatial 
Stroop task) in the Test Battery 
on Attentional Performance 
(Zimmermann & Fimm, 1993) 
33 Hypothetical Delay 
Discounting Task (Johnson & 
Bickel, 2002) 
34 Quick Discounting Operant 
Task (Johnson, 2012) 
 Decision making 
35 Iowa Gambling Task (Bechara 
et al., 1994) 
 
 Frontal  
36 Frontal Assessment Battery 
(Dubois, 2000)  
37 Colour-Word-Association Test 
(Linden et al., 1990)   
38 Trail Making Test A (Halstead, 
1947) 
39 Trail Making Test Part B 
(Reitan & Wolfson, 1995) 
40 Color Trail Test (Satz, 
Uchiyama & White, 1996) 
 
 Problem Solving and 
Reasoning 
41 Twenty Questions (Laine & 
Butters, 1982) 
42 Hypothesis Testing Procedure 
(Levine, 1966) 
43 Adaptive Skills Battery (Jones 
& Lanyon, 1981) 
44 Conceptual Level Analogy 
Test (Willner, 1970) 
45 Raven’s Standard Progressive 
Matrices (Raven, 1998) 
46 Problem Solving cluster score 
(Yohman et al., 1988) 
  
Concept Formation and 
Abstraction Ability 
47 The Category Test (Halstead, 
1947) 
48 Concept Formation Test (Rao, 
1976) 
49 Abstraction Test (Shipley, 
1940) 
 
 Cognitive Flexibility and 
Fluency  
50 Wisconsin Card Sorting Test 
(Heaton, 1993) 
51 Phonemic fluency (Lezak, 
Howieson & Loring, 2004) 
52 Semantic fluency (Strauss, 
Sherman & Spreen, 2006)   
 
 Visuospatial Construction and 
Planning 
53 WAIS Block Design 
(Weschler, 1981) 
54 Complex Figure Test copy 
(Lezak et al., 2004) 
55 Rey Figure Test copy (Lezak, 
1983) 
56 Perceptual motor cluster score 
(Yohman et al., 1988) 
 
 Global Cognition 
 
57 Mean T score for battery of 
tests (Fals-Stewart & Lucente, 
1994) 
58 MMSE (Folstein, 1975) 
59 The Neuropsychological 
Assessment Battery-Screening 
Module (White, Stern & Staff, 
2003) 
  
Treatment Outcomes 
 
60 Staff Rating Scale (Sacks & 
Levy, 1979) 
61 Working Alliance Inventory-
Short Form (Busseri & Tyler, 
2003) 
62 Client Assessment Summary 
(Kressel, De Leon, Palij & 
Rubin, 2000) 
63 Length of stay in treatment 
(days) 
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64 Readiness for treatment (TCU 
Self Rating Form; Czuchry & 
Dansereau 2000)  
65 Peer ratings of treatment 
engagement (Czuchry, 
Dansereau, Sia & Simpson, 
1998)  
66 Community ratings of 
treatment engagement 
(Czuchry & Dansereau, 2000)  
67 Graduation rate 
68 Relapse Prevention Content 
Test (Roehrich & Goldman, 
1993) 
 
  
 
Substance Use 
 
69 Timeline Followback 
Interview: Percent Days 
Abstinent, Drug Use (Sobell & 
Sobell, 1996) 
70 Addiction Severity Index 
(McLellan et al., 1992) 
71 Urine drug screen 
72 Obsessive Compulsive 
Drinking Scale German 
Version (Mann & Ackermann, 
2000) 
73 Abstinence/Relapse 
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Risk of Bias in Included Studies 
A summary of the risk of bias across studies is presented in Figure 2.  
Figure 2. Risk of Bias Summary 
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Allocation 
Three studies (Bell et al., 2016; Fals-Stewart & Lam, 2010; Gamito et al., 2014) 
were deemed to be at low risk of bias for random sequence generation. This was based 
on adequate randomisation methods in the published reports (namely use of random 
number generator/urn randomisation). Twelve studies were rated as having an unclear 
risk of bias, as they were described as ‘randomised’ but with insufficient details about 
methods to make a judgment about possible bias (Czuchry & Dansereau, 2003; Fals-
Stewart & Lucente, 1994; Goldman & Goldman, 1987; Grohman & Fals-Stewart, 
2003; Mathai et al., 1998; Roehrich & Goldman, 1993; Rupp et al., 2012; Steingass et 
al., 1994; Stringer & Goldman, 1998; Wetzig & Hardin, 1990; Yohman et al., 1988). 
All 15 studies were rated as unclear for allocation concealment as no details were 
reported on concealing the allocation sequence prior to assignment.  
 
Blinding 
The behavioural nature of the interventions could not be kept blind from 
participants and personnel. As a result, blinding of participants and personnel was rated 
as high risk of bias by default. Regardless of the inability to blind participants and 
personnel, it was possible to reduce bias for all outcomes by recruiting someone not 
otherwise involved in the study to measure outcomes without knowledge of allocation. 
Three studies were rated as low risk of bias for reporting outcome assessors as blind 
(Fals-Stewart & Lam, 2010; Gamito et al., 2014; Rass et al., 2015). For eleven studies, 
it was not reported and thus the bias was rated as unclear (Czuchry & Dansereau, 2003; 
Fals-Stewart & Lucente, 1994; Goldman & Goldman, 1987; Grohman & Fals-Stewart, 
2003; Mathai et al., 1998; Roehrich & Goldman, 1993; Rupp et al., 2012; Steingass et 
al., 1994; Stringer & Goldman, 1998; Wetzig & Hardin, 1990; Yohman et al., 1988). 
39 
 
One study was rated as high risk of bias as outcome assessors were not blind to 
participants’ intervention group (Bell et al., 2016).  
 
Incomplete Outcome Data 
Three studies were deemed to be high risk for attrition bias. Both Gamito and 
colleagues (2014) and Rass and colleagues (2015) had high levels of attrition and 
excluded dropouts from the analyses, and Rupp and colleagues (2012) had uneven 
levels of attrition between groups and it was not reported whether dropouts were 
included in the analysis. Seven studies were considered to be low risk for attrition bias 
(Bell et al., 2016; Fals-Stewart & Lucente, 1994; Fals-Stewart & Lam, 2010; Mathai 
et al., 1998; Roehrich & Goldman, 1993; Wetzig & Hardin, 1990; Yohman et al., 
1988). This was due to low rates of attrition (<20%) which was balanced across groups 
or as imputation was likely to have appropriately accounted for missing data. Five 
studies were rated as having unclear risk of bias (Czuchry & Dansereau, 2003; 
Goldman & Goldman, 1987; Grohman & Fals-Stewart, 2003; Steingass et al., 1994; 
Stringer & Goldman, 1998) as levels of attrition or subsequent numbers analysed were 
not reported.  
 
Selective Reporting 
Three studies were rated as being at high risk of bias for selective outcome 
reporting; these were the only studies that had prospectively registered a trial protocol. 
One study (Gamito et al., 2014) omitted reporting the post-treatment MMSE from the 
paper despite stating this as a primary outcome in the protocol (see Appendix 2 for 
more details, including author correspondence), another study (Bell et al., 2016) did 
not report all outcomes stated in the protocol in the paper, and a third study (Rass et 
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al., 2015) reported several outcomes in the paper that were not pre-specified in the 
registered protocol. 
For the remaining 12 studies, the risk of selective reporting was rated as unclear 
as outcomes could not be checked against a prospectively registered protocol (Czuchry 
& Dansereau, 2003; Fals-Stewart & Lucente, 1994; Fals-Stewart & Lam, 2010; 
Goldman & Goldman, 1987; Grohman & Fals-Stewart, 2003; Mathai et al., 1998; 
Roehrich & Goldman, 1993; Rupp et al., 2012; Steingass et al., 1994; Stringer & 
Goldman, 1998; Wetzig & Hardin, 1990; Yohman et al., 1988).  There is a tendency 
for these to be older studies, conducted when reporting standards were not as strict as 
they are for current RCTs. 
 
Other Sources of Bias 
One study was considered to be at high risk of other types of bias (Mathai et 
al., 1998) as the intervention group received additional interventions to the treatment-
as-usual group, and had a small sample size (N = 8). The other 14 studies were rated 
as low risk of bias, as no other biases were identified such as baseline imbalances.  
 
Effects of Interventions 
The study findings were considered by outcome. For convenience and clarity, 
these were classified under the domains of: declarative memory, working memory, 
attention, executive function, global cognition, treatment outcomes and substance use 
outcomes. Where possible, risk of bias judgments were integrated into the study 
results. 
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Declarative Learning and Memory 
Six studies assessed verbal learning and memory outcomes. Three studies 
testing interventions that broadly targeted attention and memory reported post-
treatment improvements for the cognitive remediation groups but not comparison 
groups (Bell et al., 2016; Mathai et al., 1998; Steingass et al., 1994). Where follow-up 
assessment was performed, improvement was sustained at 3 months (Bell et al., 2016). 
One study (Rupp et al, 2012) found a significant improvement only for delayed verbal 
recall, and non-significant effects between groups for verbal immediate recall, learning 
and recognition.  
One study did not find a significant improvement in the cognitive training 
group (Rass et al., 2015). Another study (Yohman et al., 1988) which reported a 
composite measure of visual memory and working memory found no effect of either 
memory training or problem solving training (the two active intervention groups) for 
the intervention compared to control group.  
Two studies reported measures relating to visuospatial memory recall, and 
neither found an effect of the intervention (Steingass et al., 1994; Rupp et al., 2012).  
 
Working Memory 
Three studies assessed working memory. One study found improvements on 
two measures of working memory (two-back paradigm and Digit Span Backwards) for 
the cognitive remediation group compared to control group, who were trained over 
multiple cognitive domains (Rupp et al., 2012). Another study trained participants 
specifically in working memory (Rass et al., 2012) and of the five measures of working 
memory assessed, there were improvements for the intervention group in two of these 
42 
 
measures (Digit Span Backwards and Visuospatial Working Memory Task) and not 
for the other three (Operation Span, Digit Span Forwards and N-back Task). 
One study (Steingass et al., 1994) of attention and memory training for 
alcoholics found no effects of the intervention over three measures of working 
memory.  
 
Attention 
Four studies reported measures of processing speed/simple attention. Two 
studies found no significant effect of the intervention on these measures (Rupp et al., 
2012; Rass et al., 2015), and two reported an effect. One of these (Mathai et al., 1998) 
found improvements on simple reaction time for the intervention group (however, note 
the high level of bias in this study), and the other (Roehrich & Goldman, 1993) found 
both remediation groups had significant improvements on Digit Symbol substitution 
compared to control groups.  
For the two studies reporting measures of sustained attention, there were no 
significant intervention effects (Mathai et al., 1998; Steingass et al., 1994), nor were 
there effects for two studies measuring divided attention (Mathai et al., 1998; Rupp et 
al., 2012). 
 
Executive Function  
Two studies measured response inhibition and impulsivity over five different 
outcome measures (Rass et al., 2015; Rupp et al., 2015). Neither study found 
significant effects of the intervention compared to control groups. 
Five studies reported measures of frontal lobe functioning. One study (Gamito 
et al., 2014) found significant improvements from baseline to follow-up in the Frontal 
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Assessment Battery in the intervention but not control group. Three studies 
administered the Trail Making Test Part B; two found an improvement in remediation 
groups (Roehrich & Goldman, 1993; Goldman & Goldman, 1987) and one did not 
(Rass et al., 2015). One study that tapped frontal functioning from the Colour-Word-
Association Test did not find an effect of the intervention (Steingass et al., 1994).  
Two studies measured outcomes relating to problem solving and reasoning. 
One study (Yohman et al., 1998) found that a group trained on problem solving did 
significantly better than the other two (memory training and control) groups on a 
cluster measure of problem solving. The other study (Rass et al., 2015), however, 
found an intervention and control group worsened post-treatment on a measure of 
reasoning.  
The only study (Mathai et al., 1998) reporting an outcome relating to concept 
formation did not find significant effects of the active intervention. 
With regards to cognitive flexibility, two studies measured the Wisconsin Card 
Sorting Test (WCST). Whereas one study (Gamito et al., 2014) found no effect of the 
intervention group compared to treatment-as-usual, the other (Wetzig & Hardin, 1990) 
found the experimental group demonstrated significantly improved performance over 
the practice and control groups on three outcomes from the WCST. 
One study (Rupp et al., 2012) measured verbal fluencies (semantic and 
phonemic) and found no effect of the intervention.  
Four studies administered outcomes measuring visuospatial construction and 
planning. Two studies administered the WAIS Block Design task. One study (Rupp et 
al., 2012) which trained alcoholics in a general computer-assisted cognitive 
remediation programme did not find an intervention effect on this measure. Another 
(Stringer & Goldman, 1998) specifically trained two groups of alcoholics on the task 
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(one remediation group was taught a strategy for constructing block designs and given 
guided practice, and one control group practiced but without the training) and found 
both remediation groups equally effective and significantly better than the control 
groups. Also, both groups’ post-test performance fell to very near that of the non-
alcoholic control group, indicating some functional recovery. Two other studies 
considered outcomes broadly under this cluster; Steingass and colleagues (1994) found 
no group effect of attention and memory training on the Rey Figure Test copy and 
Yohman and colleagues (1988) found no effect of problem solving or memory training 
on a perceptual motor cluster score of outcomes.  
 
Global Cognition  
Four studies reported a measure of global cognition. Two of these measured 
the MMSE (Folstein, 1975). Whereas Gamito and colleagues (2014) found no 
difference between groups post-treatment following an mHealth multi-domain 
cognitive intervention, Rupp and colleagues (2012) found a post-treatment 
improvement in MMSE score in the computer-assisted cognitive remediation group 
compared to the treatment-as-usual group.  One study presented a summary score for 
a battery of neuropsychological tests rather than reporting outcomes individually 
(Fals-Stewart & Lucente, 1994). At post-treatment the computer-assisted cognitive 
rehabilitation group were not significantly different from the three control conditions 
on this main outcome measure. The other study to report a global measure of cognition 
(Fals-Stewart & Lam, 2010) found a significant improvement on the NAB-SM for a 
computer-assisted cognitive rehabilitation group versus an active control group at 
nine-week post-treatment assessment. However, this outcome was not reported at 
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follow-up assessments (three, six, nine and 12 months) so it is unclear whether the 
effect was sustained.  
 
Treatment Outcomes  
Five studies considered whether cognitive remediation interventions had an 
effect on substance-use treatment outcomes. One study (Roehrich et al., 1993) tested 
an instrument assessing acquisition of the elements of relapse prevention (RP), and the 
remediation groups improved in RP content acquisition and cognitive flexibility 
compared to control groups, with the standard neuropsychological stimulation group 
slightly outperforming the ‘ecologically valid remediation’ group. Another study 
(Czuchy & Dansereau, 2003), a large cluster-RCT which compared probationers 
receiving Cognitive Skills Modules in addition to inpatient treatment-as-usual, 
considered: readiness for treatment, peer ratings of treatment engagement and 
community ratings of treatment engagement. Effects were found for the intervention 
groups at mid- and post-treatment for readiness for treatment, peer-ratings (of working 
the programme and for being clean and sober), and increased community engagement 
and respect, but differences were bigger at mid-term than post-treatment.  
For the two studies (Fals-Stewart & Lucente, 1994; Fals-Stewart & Lam, 2010) 
measuring staff ratings of patient participation the cognitive remediation groups had 
higher scores on each month of measurement. In addition, Fals-Stewart & Lam (2010) 
found the cognitive remediation group participants had significantly higher scores on 
another two measures of treatment engagement (WAI-S and CAS).  
Finally, for the two studies that considered length in treatment and graduation 
rate, it was found that the intervention groups stayed in treatment longer and a greater 
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proportion of patients who received the intervention graduated from the programme 
successfully (Fals-Stewart & Lam, 2010; Grohman & Fals-Stewart, 2003).  
 
Substance Use Related Outcomes 
With regards to substance use outcomes, two studies measured the Addiction 
Severity Index (McLellan et al., 1992). Whereas one study (Fals-Stewart & Lam, 
2010) found that the intervention group showed improvement on some ASI composite 
measures (Alcohol, Drug, Legal, Family-Social) at 12-month follow-up, the other 
study (Rass et al., 2015) found that the only composite of the ASI to be significantly 
different at post-treatment was Employment Status. Both studies also reported 
intervention groups having fewer drug use days and a higher percentage of days 
abstinent at post-treatment compared to control participants. Another study (Mathai et 
al., 1998), which has questionable validity due to high risk of bias, reported no effect 
of the cognitive intervention on rates of abstinence and relapse at one-month follow 
up. Finally, Rupp and colleagues (2012) measured alcohol cravings (OCDS-G) and 
found that compulsions were significantly lower for the intervention group, but not 
obsessions.  
 
Discussion 
 
Summary of Main Results 
This study reviews RCTs of cognitive remediation for adults with SUDs, with 
a view to understanding whether the interventions lead to improvement in cognition 
or positively impact treatment outcomes. The review highlights the clinical 
heterogeneity across the existing studies, and the large number of cognitive outcome 
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measures used. Using a narrative approach to synthesise results across outcomes 
(cognitive, treatment and substance-related), overall results are mixed and the evidence 
for cognitive remediation is weak across many of the comparisons.  
For cognitive outcomes, the evidence is limited and inconclusive. There is 
some evidence for the effect of memory/attention training on remediating verbal 
learning and memory (over three studies; Bell et al., 2016; Mathai et al., 1998; 
Steingass et al., 1994), sustained to three months (Bell et al., 2016). There is also some 
evidence for improvements in measures of frontal lobe function following cognitive 
remediation (two multi-domain interventions [Gamito et al., 2014; Roehrich & 
Goldman, 1993] and one specific-task intervention [Goldman & Goldman, 1987]), 
although this is not consistently found across other studies. With regards to 
visuospatial construction and planning, there was some evidence for improvements 
after specific training in a task on post-treatment performance (Stringer & Goldman, 
1998) – however, a multi-domain computer-assisted remediation intervention had no 
effect (Rupp et al., 2012). This may indicate that training on a specific cognitive task 
may increase one’s performance on that task, but that general cognitive programmes 
may not lead to transfer-effects on measures. There is mixed evidence on studies 
reporting measures of global cognition and working memory. There is little evidence 
for visuospatial memory recall, attention and response inhibition/impulsivity.  
With regards to treatment and substance use outcomes, there is some indication 
that cognitive remediation may improve measures indicating treatment engagement 
and acquisition. More promising is some evidence of improvement in objective 
measures of length in treatment and graduation rate, which favour cognitive 
remediation over control groups (these two studies had two of the largest Ns [Fals-
Stewart & Lam, 2010; Grohman & Fals-Stewart, 2003]). Similarly, there is some 
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evidence favouring cognitive remediation groups with regards to fewer drug use days 
and a higher percentage of days abstinent.  
 
Overall Completeness and Applicability of Evidence 
The limited number of studies within each narrative comparison weakens the 
extent to which conclusions can be drawn, and thus the applicability of the evidence 
to true estimates of effectiveness. All studies recruited participants from addiction 
services, which renders the findings of the review applicable to those engaged in 
treatment for their substance use. However, participants who volunteered to participate 
in research may not be representative of all patients with SUDs, potentially 
representing a more motivated subgroup. Very few studies had follow-up assessments 
and therefore we cannot make inferences that any of the favourable effects found post-
treatment would be sustained. The acceptability of the interventions to individuals with 
SUDs was not reported in any study. It would be useful to know how participants 
found the cognitive remediation tasks, for example, whether they would commit to it 
as part of treatment, or whether they were able to focus and engage with it. Although 
a few studies reported treatment and substance use outcomes, the evidence remains 
limited as to whether any of the limited improvements in cognitive functioning 
translate to meaningful effects in real-life.  
 
Quality of the Evidence 
The risk of bias for each study and across bias domains has been reported in 
detail previously and summarised in Figure 2. None of the included studies reported a 
power calculation, and there is a chance that the smaller studies may have missed real 
effects. Seven studies had small samples under 65 participants (Bell et al., 2016; 
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Mathai et al., 1998; Rass et al., 2015; Rupp et al., 2012; Steingass et al., 1994; Stringer 
& Goldman, 1998; Wetzig & Hardin, 1990). Three studies had large samples over 100 
(Czuchry & Dansereau, 2003 [N = 452]; Fals-Stewart & Lam, 2010 [N = 160]; 
Grohman & Fals-Stewart, 2003 [N = 120]). Given there were no significant high risk 
of biases identified for these trials (however, judgements were often unclear due to 
poor reporting) perhaps more weight should be given to these studies. The latter two 
studies (Fals-Stewart & Lam, 2010; Grohman & Fals-Stewart, 2003), which both 
offered computerised cognitive remediation interventions, found favourable effects on 
treatment and substance use outcomes. The largest trial (Czuchry & Dansereau, 2003), 
a cluster-randomised study which offered self-study booklets to communities 
randomised to the intervention, was less promising with some effects for ‘soft’ 
measures of treatment engagement and more effective at mid-treatment than post-
treatment.  
Of particular concern is the fact that all three RCTs that pre-registered a trial 
protocol (Gamito et al., 2014; Bell et al., 2016; Rass et al., 2015) did not all follow the 
procedure they had pre-specified and omitted reporting of some measures, rendering 
them at high risk for selective outcome reporting and questioning the study results. 
There were other concerns with these three papers, including the testing of a large 
number of outcomes. For example, Gamito and colleagues (2014) reported 14 
cognitive measures which increases the chance of finding a chance positive result or 
“cherry picking” an outcome to report.  
 
Potential Biases and Limitations of the Review Process 
There are potential biases and limitations in the review process that should be 
considered when interpreting the findings.  
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Cognitive measures were categorised under a single cognitive domain. 
Categorising outcome measures was a challenge, as several measures are likely to tap 
several cognitive functions (e.g. both attention and memory), as few tasks require 
cognitive skills that operate in isolation. These crude decisions made about 
categorisation will have affected the inferences drawn about the effectiveness as this 
was done by outcome type.  
There was high heterogeneity across the intervention content (for example, 
some interventions which trained a specific task/domain and others that trained several 
cognitive skills), delivery format (computerised, self-study booklets, or group-
delivered) and amount of intervention received (two sessions of remediation up to 50). 
This may weaken the strength of conclusions that can be drawn from collating studies 
by outcome (i.e. grouping what may in practice have been quite different ‘cognitive 
remediation’ interventions). There was also heterogeneity across the populations 
samples (e.g. in setting [country and type of treatment programme], type of SUD, and 
severity of cognitive impairment at baseline) which may have affected the degree of 
any benefits of remediation.   
Three comprehensive databases were searched to identify trials. However, due 
to time and resource constraints, not all relevant electronic databases were searched 
and so there is a chance some studies could have been missed. This is a possibility 
given that two of the included studies, identified from review papers, were not 
identified in the original search. In addition, grey literature was not searched.  This 
could suggest a risk of publication bias, which may overestimate the effects of 
interventions (as studies finding a positive result are more likely to be published; 
Winters & Wier, 2017).   
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The review was biased to randomised studies only; this may have affected the 
review findings if higher quality studies differ systematically from other studies on 
characteristics other than study quality. 
Although a second individual rated risk of bias for each study, only one author 
scanned the search results, made decisions on inclusion and exclusion, extracted data 
from included studies, and categorised cognitive outcome measures. Ideally these 
processes would have been done by two authors to reduce human error and implicit 
individual biases.   
Finally, it was a challenge to integrate study risk of bias judgments into results 
and conclusions. It is important to keep these in mind in weighting the applicability of 
the evidence. 
 
Conclusions 
At present, the findings are not sufficiently consistent to be evidence for 
recommending cognitive remediation as an adjunct to addiction programmes. 
However, there is some evidence from a small number of studies that some cognitive 
remediation interventions may have an effect on treatment outcomes. There is some 
promise in computerised cognitive remediation programmes that warrant further 
research. The estimates of effectiveness are not very clear given some of the 
methodological limitations and significant clinical heterogeneity across studies.  
 
Implications for Practice 
There is no clear indication at present that cognitive remediation would be a 
useful adjunct to treatment. There is, however, substantial evidence that cognitive 
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impairments are prevalent across SUDs so perhaps focusing on tailoring treatments 
that have an evidence-base to adapt for this could prove more useful.  
 
Implications for Research  
Following the review, several recommendations for future research follow. It 
would be useful for future studies to use a small set of robust cognitive outcome 
measures that would allow for direct comparison. It would also be useful, when 
considering the wider implications of remediating deficits with regards to treatment 
adherence and reducing substance use, to test whether cognitive outcomes transfer to 
these more clinically-relevant outcomes.  Follow-up assessments should be carried out 
to determine whether any effects are sustained. In addition, should any robust evidence 
be found in future trials, an effectiveness trial testing the feasibility and acceptability 
of the intervention in addiction services would be the necessary next step.  
It could also be useful to consider who does and does not respond to cognitive 
remediation intervention - i.e., whether a severity of deficit or long history of substance 
use negates the ability to benefit from the intervention.  
Although the review focused on interventions that targeted top-down cognitive 
functions, there is recent suggestion in the literature that interventions targeting both 
top-down and bottom-up cognitive functions could prove more promising (Manning, 
Verdejo-Garcia, & Lubman., 2017).  
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Abstract 
 
Background. Frequent cannabis users have been found to show impaired memory for 
past events, but it is not clear whether they are also impaired in prospective memory 
for future events. Aims. To objectively assess prospective memory (PM) in frequent 
cannabis users (one group dependent on cannabis, and one group non-dependent) 
compared to non-using controls, and to examine the effects of future event simulation 
(FES) on PM performance. To explore depression, anxiety and ‘schizotypy’ across 
groups. Design. An independent groups design. Setting. University College London. 
Participants. Fifty-four participants (18 dependent cannabis users, 18 non-dependent 
cannabis users and 18 controls) took part and were matched on age, gender, and highest 
level of education. Measures. The Virtual Week was used to assess PM abilities, with 
and without FES. Other measures: Cannabis Use Potency Questionnaire (CPU-Q), 
immediate and delayed prose recall, phonemic and category fluency, Spot-the-Word, 
Beck Depression Inventory (BDI-II), Beck Anxiety Inventory (BAI), and a measure 
of schizotypy (O-LIFE: Unusual Experiences). Results. There were no group 
differences in PM performance on the Virtual Week, and FES did not improve PM 
performance. Dependent cannabis users scored higher on depression, anxiety and 
schizotypy than both other groups (non-dependent cannabis users and controls, who 
scored similarly). Conclusions. When carefully matched on baseline variables, 
cannabis users do not differ from non-using controls on PM. Suggestions for future 
research are discussed. 
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Introduction 
 
 Cannabis is the most commonly consumed illicit drug in the world, with an 
estimated 120-190 million users worldwide (United Nations Office on Drugs and 
Crime, 2015). Cannabis is a psychoactive drug which comes in various forms, and is 
either smoked, inhaled as vapour, or ingested orally. It is used medically (e.g. for 
reducing symptoms in chronic pain and spasticity; Whiting, Wolff & Deshpande, 
2015), in religious rituals, and for pleasure. There are around 90 chemical compounds 
within the plant, known as cannabinoids, but the major active cannabinoid by which 
the plant exerts its desired psychoactive effects is THC (∆9, tetrahydrocannabinol). 
THC produces a euphoric high, feeling of relaxation, and intensification of sensations, 
among other physiological and cognitive effects (Curran & Morgan, 2014; 
McLoughlin et al., 2014).  
 High doses of THC can also cause acute, transient psychosis-like symptoms 
(D’Souza et al., 2005), and there is an association found between high-potency 
cannabis use and psychosis (di Forti et al., 2015; Ferraro et al., 2013). Frequent 
cannabis use has also been associated with depression and anxiety. A cohort study (N 
= 14,531; Cheung et al., 2010) found the highest levels of anxiety and mood disorders 
were in those who smoked cannabis almost every day (18.1%), compared to those 
smoking more infrequently or not at all (8.7%).  Another large cohort study (N = 
42,862; Grant & Pickering, 1998) found more severe comorbidity was associated with 
cannabis dependence, hypothesising that cannabis may be used to self-medicate 
depression. This finding has been replicated recently in a community sample (N = 521) 
of frequent cannabis smokers, with the study finding that mood and anxiety problems 
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were highest in the dependent users compared to non-dependent users (who smoked 
the same amount), with the non-dependent users scoring similarly to the general 
population sample (van der Pol et al., 2013).  
 Long-term cannabis use has also been linked to acute impairment of cognitive 
functioning, including decision-making (Whitlow et al., 2004), executive functioning 
(Bolla, Brown, Eldreth, Tate & Cadet, 2002), memory (Curran et al., 2016), and word 
fluency (Croft, Mackay, Mills & Gruzelier, 2001). These cognitive effects are thought 
to be mediated by Type 1 cannabinoid (CB1) receptors, which are found in frontal and 
temporal brain regions (Mechoulam & Parker, 2013).  A meta-analysis of 13 studies 
indicates that these acute cognitive effects may be reversed after a period of abstinence 
(Schreiner & Dunn, 2012), and the length of abstinence is associated with the extent 
of the reversal of the cognitive effects (Schoeler, Kambeitz, Behlke, Murray & 
Bhattacharyya, 2016).  
Smoking high-potency forms of cannabis (i.e. with high levels of THC) has 
been associated with a greater severity of dependence and more pronounced cognitive 
effects, compared to smoking less potent forms of the drug. Higher levels of 
cannabidoil (CBD) can moderate some of the negative effects of THC (Curran et al, 
2016; Freeman & Winstock, 2015). Although general rates of cannabis use are falling 
in the UK (Home Office, 2014), there is increasing popularity of more potent forms of 
cannabis with THC levels of 15% or more, often called ‘skunk’. Rising THC 
concentrations have been found from cannabis seizure data in the UK (Hardwick & 
King, 2008), Europe (EMCDDA, 2014) and the USA (ElSohly et al., 2016).  
 One of the most frequently reported and robust effects seen in cannabis users 
relates to memory performance (Bolla et al., 2002; Curran et al., 2016; Schoeler, 
Kambeitz, Murray & Bhattacharyya, 2016). Laboratory-based studies on memory 
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suggest that long-term use of cannabis may have significant effects on memory, 
including impairments in encoding, storage, manipulation and retrieval (Solowij & 
Battisti, 2008). However, despite the wealth of evidence on the effects of cannabis use 
on retrospective memory, research into the effects on future-based memory processes 
remains relatively neglected.  
One vital aspect of everyday memory is prospective memory (PM), which is 
the ability to enact intended actions at a certain point in the future, i.e. forming an 
intention followed by the execution of that intended action after a delay (Rendell & 
Henry, 2009). To-be-remembered actions may be event-based (e.g. collecting a 
prescription when passing a GP surgery), time-based (e.g. meeting a friend at 18:00) 
or activity-based, requiring an action to be performed following the accomplishment 
of another activity (e.g. calling the doctor after posting a letter). As such, these forms 
of PM depend on whether the cue for PM performance is the appearance of a certain 
stimulus (event-based), the passage of a certain amount of time  (time-based) or the 
end of an activity (activity-based). Actions may be regular (e.g. taking medication 
every morning), or irregular (e.g. one-off actions, such as a dentist appointment).  
 It is thought that PM ability is reliant on retrospective memory to retain 
knowledge of the intention, the cue, and executive planning and motivation functions, 
to coordinate intended actions (Burgess, Simons, Coates & Channon, 2005). Deficits 
in PM may hold broad implications for occupational, interpersonal and/or health 
related functioning through failure to enact intended actions (Fish, Manly & Wilson, 
2009).  
 PM is an emerging area in substance use research. Impairments in PM 
performance have been found in alcohol dependence (Griffiths et al., 2012), 
methamphetamine users (Rendell, Mazur & Henry, 2009), long-term opiate users 
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(Terrett et al., 2014), heavy social drinkers (Platt, Kamboj, Italiano, Rendell & Curran, 
2016) and MDMA users (Montgomery, Hatton, Fisk, Ogden, & Jansari, 2010). Aside 
from the everyday implications, PM deficits may also impair a user’s ability to apply 
planned relapse prevention strategies in those aiming to reduce or stop their substance 
use. 
 To date, several studies have investigated PM in cannabis users (Bartholomew, 
Holroyd & Heffernan, 2010; Bedi & Redman, 2008a; Bedi & Redman, 2008b; Cuttler, 
2012; Fisk & Montgomery, 2008; Gallagher et al., 2014; Hadjiefthyvoulou, Fisk, 
Montgomery & Bridges, 2011; McHale & Hunt, 2008, Montgomery & Fisk, 2007; 
Montgomery, Seddon, Fisk, Murphy & Jansari, 2012; Rodgers et al., 2001; Rodgers 
et al., 2003). However, many of these studies have significant methodological 
limitations, making it difficult to attribute any observed effects specifically to cannabis 
use.  
 There is an important distinction to be made between studies using self-report 
PM questionnaires (e.g. the Prospective Memory Questionnaire [PMQ]; Hannon, 
Adams, Harrington, Fries-Dias & Gipson, 1995), which tap into a range of PM errors 
in everyday life, and those using objective measures of memory performance in the 
laboratory setting or in a real-world context. Several studies of PM in cannabis users 
have used self-report measures, and the results are inconsistent. Two self-report studies 
have found cannabis use to be associated with PM deficits (Fisk & Montgomery, 2008; 
Montgomery & Fisk, 2007) and three did not find an impairment in users (Bedi & 
Redman, 2008a; Rodgers et al., 2001; Rodgers et al., 2003). In the two studies finding 
a PM deficit using the PMQ (Fisk & Montgomery, 2008; Montgomery & Fisk, 2007) 
a non-standard and loose definition of cannabis use was used (lifetime use of cannabis 
regardless of frequency and chronicity, in a sample of poly-drug users). Self-report 
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measures which tap self-perception of PM are prone to inaccuracy in reporting due to 
failures in accurately recalling lapses in memory, and as self-rated cognitive abilities 
tend to pick up on performance anxiety. These two studies also suffered from other 
critical methodological limitations such as the questionable validity of the PMQ (Uttl 
& Kibreab, 2011). 
 More objective measures of PM have been used to examine performance in 
cannabis users, such as a video-based task (Titov & Knight, 2001) that requires 
participants to move through a shopping precinct and carry out pre-assigned tasks, and 
another video-based task requiring participants to play the role of an office worker for 
a day with a list of tasks to be completed for the office manager (Jansari, Agnew, 
Akesson, & Murphy, 2004).   A systematic review and meta-analysis (Platt, 2014) of 
objective PM measures found cannabis users to perform significantly worse than 
healthy controls on irregular event-based PM tasks over six studies (g = .43, 95% CI 
[.02, .83], Z = 2.07, p < .001), but with large statistical heterogeneity between studies 
(I2 = 76%). While two of these studies found cannabis use to have no effect on PM 
(Cutler et al., 2012; Gallagher et al., 2014), four studies reported either small 
(Hadjiefthyvoulou et al., 2011), medium (Bartholomew et al., 2010; Bedi & Redman, 
2008b) or large effects (Montgomery et al., 2012). With regards to irregular time-based 
PM performance (five studies), cannabis adversely affected performance (g = .43, 95% 
CI [.02 - . 83], Z = 3.31, p = < .001). Effect sizes were medium to large, with only one 
study reporting no effect (Cuttler et al., 2012). One study (Gallagher et al., 2014) 
examined regular PM (time-based), and the effect was small (g = .31, 95% CI [-.10 - 
.71]).  
Many of the studies in the systematic review failed to use a reliable and 
objective measure of participants’ cannabis use to determine their allocation to 
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cannabis or comparison groups. For example, the studies varied from defining 
cannabis groups as using ‘some cannabis use in the past year’ (Bartholomew et al., 
2010), to ‘at least once a month for the past six months’ (McHale & Hunt, 2008) to ‘at 
least four times in the last month’ (Montgomery et al., 2012). Similarly, tasks varied 
from a short 10-minute PM video task, to ones tapping PM over a much longer time 
period (e.g. returning an envelope to the researcher one, two and three weeks after a 
short-term memory task with any words they could recall; Gallagher et al., 2014).   
 A separate series of studies, not on cannabis users, have shown deficits in PM 
may be overcome by a planned and deliberate cognitive rehearsal strategy. Future 
event simulation (FES) involves pre-experiencing future events using a structured 
mental imagery task (Schacter, Addis, & Buckner, 2008). FES involves instructing the 
participant to vividly imagine performing a future action during encoding. The 
constructive episodic simulation hypothesis supposes that episodic memory combines 
the details of past experiences (e.g. objects, people and locations) to depict potential 
future events (Schacter et al., 2008). There is evidence that FES may improve PM 
performance on an objective measure of PM, the Virtual Week (VW; Rendell & Craik, 
2000) for event-based tasks in heavy drinkers (Platt et al., 2016), and for those acutely 
administered alcohol on event-based tasks (Paraskevaides et al., 2010). However, on 
a study also assessing VW performance in alcohol-dependent individuals compared 
to social drinkers (Griffiths et al., 2012), there was no effect of FES on PM for the 
dependent group, but an improvement for social drinkers on time-based PM.  
 
Aims  
 The present study sought to determine PM performance measured by the VW 
in both dependent and non-dependent frequent cannabis users (both groups using 
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cannabis four or more days a week) compared to non-using controls, and whether any 
task performance increment was observed through use of FES. Given the role of 
memory and executive function in PM processes, these domains of cognition were also 
assessed to determine their contribution to any observed differences in PM. We also 
explored levels of depression, anxiety and schizotypy (‘psychosis-proneness’) across 
the groups.  
Importantly, this is the first study to assess both regular and irregular time- and 
event-based PM in frequent cannabis users (dependent and non-dependent) and to 
explore the effects of FES on performance.  The cannabis users were to both use 
frequently (four or more days a week) 
Findings from this study may have clinical relevance for substance use 
treatment, which is especially pressing given that demand for cannabis use treatment 
in addiction services continues to rise (NDTMS, 2015). Within the relapse prevention 
model, applying coping skills when faced with situations at high risk of relapse would 
rely in part on PM skills (Blume, Schmaling, & Marlatt, 2005), as would implementing 
intended strategies in generic cognitive behavioural therapy. If it were to be found that 
FES can improve PM, it could be suggested as a clinically useful addition to existing 
psychosocial treatments for cannabis users by compensating for a deficit in the ability 
to simulate future events. However, it is important to note that the systematic review 
in Part 1 of this paper on cognitive remediation for substance use found no conclusive 
evidence at present that cognitive training should be indicated as an adjunct to 
addiction treatment.  
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Hypotheses  
Drawing on previous research outlined above, we hypothesised that cannabis 
users would have a deficit in irregular event- and time-based PM compared to controls. 
We hypothesised that dependent users would show a greater irregular PM deficit than 
non-dependent users. Although there is only one study on which hypotheses related to 
regular PM task performance can be based (Gallagher et al., 2014), we hypothesised a 
similar pattern in the current study, that there would be poorer regular PM performance 
in cannabis users compared to controls. We had no hypotheses regarding FES due to 
a lack of directly relevant research; however, we intended to compare it directly with 
Griffiths and colleagues (2012) who found that alcohol-dependent individuals did not 
benefit from FES but that the comparison group of social drinkers did for time-based 
irregular PM. Finally, we hypothesised that dependent cannabis users would score 
higher on depression and anxiety than non-dependent cannabis users and controls, in 
line with previous research findings.  
 
Method 
 
Participants 
 
Sample Size 
 Sample size was calculated using a statistical power analysis on G*power 
(Faul, Erdfelder, Lang & Butchner, 2007), specifying p = .05 and power = .80. Using 
a medium effect size (ηp2=0.11) from an analysis detecting a difference between 
cannabis users compared to a control group on an objective measure of PM 
(Bartholomew et al., 2010), projected sample size to detect an interaction between 
74 
 
group and baseline PM performance was N = 42. However, as there was greater 
uncertainty for the other analyses (e.g. as there has been no PM study with FES on 
cannabis users), a larger sample size was recruited to partially overcome any 
underestimation of effect size in the power calculation. We therefore invited 56 
participants (18 per group) to take part in the study.  
 
Recruitment 
 Participants were recruited throughout 2016. Posters were displayed on 
noticeboards at local university campuses in the central London area and distributed 
around some public areas such as Camden Lock, and adverts were posted on social 
media websites (Twitter, Facebook and Gumtree). Snowball sampling was also used.  
 Interested individuals were emailed the Study Information Sheet (see 
Appendix 3), and, if still interested, a telephone screening interview was arranged.  
 
Telephone Screening: Inclusion and Exclusion Criteria 
 A telephone screening was used to determine eligibility for the study and took 
approximately five minutes. A copy of the screening script is in Appendix 4. Our 
inclusion criteria for the cannabis sample was to be using the drug four or more days 
a week (i.e. more days than not). We also collected additional information about 
cannabis use during the telephone screening: age at which participants started using 
cannabis, number of grams per week, and score on the 5-item Severity of Dependence 
Scale (SDS; Gossop et al., 1995). We classified users as dependent (score ≥3) or non-
dependent (score <3). According to Swift and colleagues (1998), a score of three or 
above indicates probable cannabis dependence, with sensitivity of 64% and specificity 
of 82% when compared to the ‘gold standard’ diagnostic criteria for cannabis 
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dependence (DSM-III-IR). Demographic information was collected for all individuals 
screened including age, gender, and highest level of education. We also asked all 
individuals about their alcohol use and use of other drugs. Control participants were 
required to have limited illicit drug use (twice a month or less) and no history of a 
substance dependence.  
 All participants were required to speak English fluently. Exclusion criteria 
included: being under 16 years old, a current or historical diagnosis of dependence on 
any substance other than cannabis or tobacco, weekly alcohol consumption exceeding 
21 units for women or 28 units for men (NHS-recommended guidelines at the time), a 
history of traumatic brain injury or stroke, a current or recent (last three weeks) 
experience of psychosis, in current treatment (psychological therapy or 
pharmacological) for a mental health problem other than anxiety or depression, a 
diagnosis of a learning disability, reading difficulties, or current use of antipsychotic 
medication or benzodiazepines.  
 All participants were asked to refrain from consuming any illicit drugs and 
alcohol on the day of the testing session, and gave their verbal agreement for this at 
the end of the telephone screening. 
 Participants from each of the three groups (dependent cannabis users, non-
dependent cannabis users, and controls) were selected as closely as possible to match 
each other in age, gender and highest level of education.  
 
Measures  
  
Prospective Memory 
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 The Virtual Week (VW; Rendell & Craik, 2000) is a virtual board game that 
requires participants to move a counter around a board by rolling an electronic die. 
Participants work their way around the board, with one circuit of the board 
representing one virtual ‘day’. The virtual time of day is shown on a clock in the centre 
of the board and the time passes as the counter moves around the board. Over the 
virtual day, there are ten green ‘E’ squares on the board to pass through. When a 
participant’s counter falls on or passes an ‘E’ square, they are instructed to click on 
the event card button on the board. This event card symbolises a time-appropriate event 
occurring in the virtual day, e.g. the first event cards depict morning activities such as 
eating breakfast, and the last event cards depict evening activities such as eating 
dinner. Each event card requires the participant to select a multiple-choice answer in 
response to a given activity, such as what to eat for breakfast. Throughout each virtual 
day, participants are assigned a number of tasks they must remember to perform at 
points later in the day (as a measure of PM). In the version of the VW used in this 
study, each day contained four ‘time-based’ tasks to be performed at specified times 
of day (as displayed on the central 24-hour clock), and four ‘event-based’ tasks to be 
performed in response to particular events (depicted on the Event Cards). See Figure 
1 for a screenshot of the VW.  
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Figure 1. The Virtual Week Board Game 
 
 
 At the start of the game, participants are informed of four regular PM tasks that 
need to be carried out on each virtual day (one circuit of the board). Two of these are 
time-based tasks (taking an asthma inhaler pump at 11:00 and 21:00) and two are 
event-based tasks (taking antibiotics with breakfast and dinner). The remaining four 
tasks are different on each virtual day and are thus irregular PM tasks. These tasks are 
designed to simulate more occasional tasks that occur in everyday life, e.g. having a 
haircut at 15:00 (time-based) or picking up some pencils from the shop (event-based). 
There are two are time-based and two event-based irregular tasks, two of these are 
presented at the beginning of the virtual day and the other two at other points 
throughout the day. Participants perform tasks by clicking the ‘Perform Task’ button 
within an Event Card, or the Perform Task button on the main board. The Perform 
Task button lists a number of tasks that the participant can choose to perform.  
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 The VW automatically registers whether a task is correctly performed, missed 
or performed late. The key variable of interest is the proportion of correctly completed 
irregular time-based, regular time-based, irregular event-based and regular event-
based tasks. Given that the VW was developed in Australia, some of the task details 
were amended prior to running the study to make it more appropriate for a UK sample. 
See Appendix 5 for a list of all the VW tasks.  
 
Episodic Memory 
 The Story Recall subtest of the Rivermead Behavioural Memory Test (RBMT; 
Wilson, Cockburn & Baddeley, 2003) is a measure of verbal episodic memory. 
Participants listen to a short passage and are asked to immediately repeat back 
everything they can remember. They then repeat the recall task after a delay. Using the 
RMBT scoring guidelines where the passage is broken into 21 sections, participants 
are awarded one point for accurate recall of each section, or half-points for partial 
recall (or a synonym). Scores are computed separately for the immediate and delayed 
conditions. 
 
Executive Function  
 Verbal fluency tasks involve the retrieval of words based on phonemic or 
semantic criteria, placing demands on executive processes as they require efficient 
verbal retrieval and recall, self-monitoring (i.e. responses that have already been 
given), self-initiation and inhibition of responses. In phonemic fluency, participants 
are asked to name as many words (excluding proper nouns) as they can beginning with 
a letter (e.g. ‘g’) in 60 seconds. The score is the total number of responses, minus 
repetitions and incorrect responses. In category fluency, participants are asked to name 
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as many words in a specific category (e.g. ‘vegetables’) in 60 seconds.  In addition to 
these well-known fluency tasks, drug-related fluencies were also measured (Goldstein, 
Woicik, Lukasik, Maloney & Volkow, 2007). In alcohol-fluency participants are asked 
to name as many alcohol-related words as they can in 60 seconds, and in cannabis-
fluency (for the groups of participants that use cannabis), participants are asked to 
name as many cannabis-related words as they can in 60 seconds. The order of each 
fluency task was counterbalanced by topic.  
 
Premorbid Intelligence 
 The Spot-the-Word test (STWT; Baddeley, Emslie & Nimmo-Smith, 1993) is 
a task requiring participants to select the real word from each of 60 letter-string pairs 
containing one word and one non-word. The STWT has demonstrated convergent 
validity with the Wechsler Adult Intelligence Scale (Yuspeh & Vanderploeg, 2000).  
 
Cannabis Use 
 In the Cannabis Potency Use Questionnaire (CPU-Q; Mokrysz, Freeman, 
Shaban & Curran, in preparation) participants are asked to select one of three pictures 
that best represents the type of cannabis they use most frequently, and to then estimate 
the approximate percentage of time they use each of the three types (Figure 2). Each 
picture shows different preparations of cannabis: high-potency floral preparation 
which typically contains very high levels of THC and little or no CBD, often referred 
to as ‘skunk’ (Picture A), compressed resin or ‘hash’, typically containing higher levels 
of CBD and lower levels of THC (Picture B) and traditional dried herbal material, 
referred to as ‘bush weed’ or ‘Thai weed’, which contains much lower levels of THC 
but little or no CBD (Picture C).  
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Figure 2. Preparations of cannabis used in the CPU-Q. 
 
 
 
 The use of pictures allows for an indirect indication of the THC and CBD levels 
in the cannabis used by participants, and avoids complications that differing 
terminologies for each variation may have on these estimations.  
 
Anxiety 
 The Beck Anxiety Inventory (BAI; Beck & Steer, 1993) is a 21-question 
multiple-choice self-report scale that measures current levels of general anxiety. The 
BAI covers 21 symptoms of anxiety, asking the participant to state how severely they 
have been bothered by each symptom over the past three days. The BAI has been used 
in previous studies into anxiety and cannabis use (Dafters, Hoshi, & Talbot, 2004; 
Troisi, Pasini, Saracco & Spaletta, 1998). The BAI has high internal consistency (α = 
.92) and high test-retest reliability over one week (r = .75). The BAI also exhibits a 
moderate correlation with the revised Hamilton Anxiety Rating Scale (r = .51) (Beck, 
Epstein, Brown & Steer, 1988).  
 
Depression 
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 The Beck Depression Inventory (BDI-II; Beck, Steer & Brown, 1996) is a 21-
item self-report questionnaire measuring the severity of a range of depressive 
symptoms experienced over the previous two weeks. Each question is scored 0 to 3. It 
demonstrates good criterion validity with a correlation of 0.71 against the Hamilton 
Psychiatric Rating Scale for Depression (Beck et al., 1996). The BDI-II has been used 
in previous studies exploring depression in cannabis users (Buckner, Keough, & 
Schmidt, 2007; Troisi et al., 1998). 
 
Schizotypy 
 The Oxford-Liverpool Inventory of Feelings and Experiences (O-LIFE; 
Mason, Claridge, & Jackson, 1995) is a measure of schizotypy, or ‘psychosis-
proneness’. The O-LIFE has four subscales: unusual experiences, cognitive 
disorganisation, introvertive anhedonia and impulsive nonconformity. Studies have 
found higher scores on schizotypy (using a different measure: the schizotypal 
personality questionnaire) in individuals who use cannabis with high concentrations 
of THC (Skosnik, Spatz-Glenn, & Park, 2001), and an association between levels of 
schizotypy (the Unusual Experiences subscale of the O-LIFE) and ratings in a future 
thinking task (Winfield & Kamboj, 2010). The Unusual Experiences subscale has been 
found to be a reliable and brief (i.e. time-efficient) scale to explore psychosis-
proneness (Mason, Linney, & Claridge, 2005).  
 
Other Measures 
 As the data was collected as part of a joint research project on future thinking 
in cannabis users, participants also completed an additional task where they were 
required to imagine hypothetical future events. This is reported elsewhere (Mansell, 
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2017). See Appendix 6 for a declaration of each person’s contributions to the joint 
research project. 
  
 
Focus Group and Pilot Testing 
 Prior to finalising the study protocol, a small focus group was held with two 
cannabis users who smoked frequently. They were recruited from an advert on social 
media. We met for 90 minutes at University College London (UCL) during which the 
proposed trial protocol was discussed, ensuring instructions were clearly understood, 
and the feasibility of the episodic foresight task (not reported here) was assessed. No 
changes or revisions to any tools or tasks were made after discussion with the group.  
 The testing session was then piloted on three volunteers, which helped to 
determine the position of breaks during the testing session.  
 
Procedure (Figure 3) 
 The study received ethical approval from the UCL Research Ethics Committee 
(ethical approval number: 5402/001; Appendix 7) in January 2016 under an 
amendment to an existing approval. Written informed consent (Appendix 8) was 
obtained prior to participants taking part. All participants attended a one-off testing 
session at the Clinical Psychopharmacology Unit at UCL. This lasted approximately 
two and a half hours including breaks, and participants were compensated £20 for their 
time. Scripts for the testing session were used for every participant to ensure 
consistency. 
 Participants from the cannabis groups were first asked to complete the CPU-
Q. All participants were then introduced to the VW (see Appendix 9 for the script 
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used). A trial day was completed to orient participants to the task; they followed the 
instructions on-screen and had an opportunity to ask questions. Participants were not 
permitted to start the VW until they could successfully articulate all of the regular PM 
tasks to ensure they had encoded the information. They were also asked to read aloud 
every event card in the game. Participants then completed their first two virtual days. 
The tester did not provide feedback on accuracy.  
 After a 10-minute break, participants were introduced to the imagining 
technique (FES) which they were instructed to use for all irregular events presented 
over the next two days of the VW. This involved imagining oneself performing a task 
in as much detail as possible, including details like the setting and course of events, 
the time of day, and the people and objects around. Participants were encouraged to 
set the task in their own daily life, and were given the example that if they were set the 
task of food shopping in the VW, they should imagine themselves shopping in the 
supermarket they would typically shop in. Participants then carried out two more days 
of the VW, prompted by the tester to imagine each irregular task for 10-seconds after 
the task had been set. After completing the VW, participants carried out future thinking 
task not reported here. They were then given a five-minute break. Participants were 
finally administered the remaining tasks in the following order: Story Recall 
(Immediate), Spot-the-Word, fluencies (verbal, category, alcohol, cannabis [cannabis 
participants only]), Story Recall (Delayed), BDI-II, BAI and O-LIFE Unusual 
Experiences. The order of the fluency tasks was counter-balanced.  
At the end of the testing session, participants were debriefed and asked whether 
they would like to receive a summary of the results after study completion (see 
Appendix 10 for the results summary sent to participants).  
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Recruitment 
Via flyers, posters & 
snowball sampling  
Telephone Screening 
Eligibility criteria checked 
SDS for cannabis participants 
 Informed Consent 
Information sheet discussed with an 
opportunity to ask questions  
Talk through and sign consent form 
 
Testing Part 1 
Cannabis Potency Use Questionnaire 
Instructions and trial day of VW 
Two days of VW: 
- 4 x event-based regular tasks 
- 4 x time-based regular tasks  
- 4 x event-based irregular tasks 
- 4 x time-based irregular tasks 
 
10-minute Break 
Testing Part 2 
FES instructions and practice 
Two more days of VW:  
- 4 x event-based regular tasks 
- 4 x time-based regular tasks  
- 4 x event-based irregular tasks (with FES) 
- 4 x time-based irregular tasks (with FES)  
Testing Part 3 
Story Recall (immediate) 
Spot-the-Word  
Fluency tasks 
Story Recall (delayed)  
BDI-II 
BAI  
OLIFE 
 
5-minute Break 
Debrief 
18 Controls  
18 Dependent 
Cannabis Users  
14 Not Eligible 
18 Non-Dependent 
Cannabis Users  
22 Controls Screened  
50 Cannabis Users 
Screened  
4 Not Eligible 
*After the VW, the participants completed a future thinking task (not reported here) 
Figure 3. Study Flow Diagram 
85 
 
Statistical Analyses  
 All analyses were performed on IBM SPSS Statistics Version 22. There was 
no missing data. Before exploring baseline data and running the main analyses, 
variables were checked for normality by observing histograms and calculating 
skewness and kurtosis Z-scores. Taking sample size into consideration, Z-scores of ≥ 
3.29 were used to index non-normality (Kim, 2013). Using this criterion, frequency of 
type of cannabis used as a percentage of all occasions (CPU-Q), amount of cannabis 
(grams per week), and the BAI data violated assumptions of normality. For non-normal 
variables measured in only two groups (i.e. cannabis-related variables), non-
parametric Mann-Whitney U tests were used to compare groups and central tendency 
and dispersion were described using medians and inter-quartile ranges (IQR). For all 
the other variables, parametric chi-squared tests were used to compare categorical 
variables, and t-tests (two group comparisons) or ANOVAs (three group comparisons) 
were used to detect group differences for continuous data. For parametric tests, means 
and SDs were reported.  
 The assumption of homogeneity of variance (as evidenced by Levene’s test) 
and normality according to our criteria (Z ≤ 3.29) was met for all VW variables. VW 
data was analysed with repeated measures ANOVAs, with Bonferroni-adjusted 
pairwise comparisons (with adjusted p-values) to explore post-hoc effects. To explore 
relationships between significant variables, Spearman’s rho correlations were 
conducted (on both parametric and non-parametric variables, to allow for direct 
comparison). Correlations were conducted with an adjusted alpha of 0.01 to minimise 
Type-I error. Data was also examined for extreme values. One participant’s score in 
one of the VW variables was 4 SDs from the mean, and was Winsorized to the next 
highest non-outlying value.  
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Results 
 
Group Demographics (Table 1) 
 The groups were well matched on baseline variables. There was no statistical 
difference between the number of males and females across the dependent cannabis 
group (nine males and nine females), non-dependent cannabis group (10 males and 
eight females) and control group (six males and 12 females), χ² (2, N = 54) = 1.94, p 
= 0.38. Similarly, the groups did not differ on age, F(2, 51) = 0.15, p = 0.89, highest 
level of education, χ² (4, N = 54) = 2.20, p = 0.67, Spot-the-Word score, F(2, 51) = 
1.00, p = 0.37, or units of alcohol consumed per week, F(2, 51) = 0.12, p = 0.89.  
 
Table 1. Group Demographics, Alcohol Use and Spot-The-Word scores across the 
Dependent Cannabis, Non-Dependent Cannabis and Control Groups  
 
 Dependent 
Cannabis 
Users 
(n = 18) 
Non-
Dependent 
Cannabis 
Users 
(n = 18) 
 
Controls 
(n = 18) 
 
n (%) n (%) n (%) 
Gender:       
  Male 9 (50) 10 (55.6) 6 (33.3) 
  Female 9 (50) 8 (44.4) 12 (66.8) 
Highest level of education:       
  GCSE or vocational 
qualification 1 (5.6) 2 (11.1) 3 (16.7) 
  A Level 8 (44.4) 5 (27.8) 5 (27.8) 
  Degree 9 (50) 11 (61.1) 10 (55.6) 
 M (SD) M (SD) M (SD) 
Age (years) 24.2 (5.1) 23.9 (3.7) 23.4 (3.7) 
Spot-the-Word score 49.5 (3.5) 47.2 (5.8) 48.6 (5.3) 
Alcohol (units consumed per 
week) 10.1 (8.1) 9.8 (6.9) 11.0 (8.8) 
 
Cannabis Use (Table 2) 
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 There were no differences between dependent and non-dependent cannabis 
users in the type of cannabis most commonly used, with both groups primarily using 
high-potency skunk. The proportions of hash and herbal preparations varied 
marginally but this was not significant, χ² (2, N = 36) = 4.13, p = 0.13. There were no 
differences between cannabis groups in: the frequency that each preparation of 
cannabis was used as a percentage of total cannabis use occasions, for skunk, U = 141, 
p = 0.52, herbal, U = 132.5, p = 0.36, and hash, U = 156.5, p = 0.86; mean age of onset 
of cannabis use, t(34) = 6.48, p = 0.52; amount of cannabis (grams) used a week, U = 
152.5, p = 0.77; or the number of days of cannabis use a week, t(34) = 1.31, p = 0.2. 
The mean SDS score in the dependent group was 4.3 (SD = 1.5), and in the non-
dependent group 0.8 (SD = 0.8), t(34) = 8.60, p < .001. The SDS had high internal 
consistency (α = 0.89). 
 
Table 2. Cannabis Use in the Cannabis Groups 
 Dependent 
Cannabis Users 
(n = 18) 
Non-Dependent  
Cannabis Users 
(n = 18) 
 
n (%) n (%) 
Type of cannabis most commonly 
used (CPU-Q):     
  Picture A – ‘Skunk’ 15 (83.3) 17 (94.4) 
  Picture B – ‘Hash’ 0  1 (5.6) 
  Picture C – ‘Herbal’ 3 (16.7) 0 
 Median (IQR) Median (IQR) 
Frequency of use of each   
cannabis type (%):   
  Picture A – ‘Skunk’ 80.5 (23) 85.0 (28) 
  Picture B – ‘Hash’ 10 (13) 7 (16) 
  Picture C – ‘Herbal’ 8 (23) 0.5 (10) 
Amount used a week (grams) 5 (4.75) 4 (4.63) 
 M (SD) M (SD) 
Days used per week 6.5 (0.7) 6.06 (1.3) 
Age started using cannabis  15.6 (2.2) 16.1 (1.9) 
SDS Score*** 4.3 (1.5) 0.8 (0.8) 
       Note: *** p <.001, ** p <.01, * p <.05 
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Neuropsychological Tests (Table 3) 
 On tasks assessing episodic memory, there were no differences across all three 
groups in immediate story recall, F(2, 51) = 1.89, p = 0.16, or delayed story recall, 
F(2, 51) = 1.39, p = 0.26. Similarly, there were no differences between dependent 
cannabis users, non-dependent cannabis users and control participants on measures of 
executive functioning: phonemic fluency, F(2, 51) = 2.28, p = 0.11, category fluency, 
F(2, 51) = 1.27, p = 0.29, and alcohol fluency, F(2, 51) = 0.48, p = 0.62. The cannabis 
sample additionally completed a measure of cannabis fluency, and their mean scores 
did not differ between the dependent and non-dependent groups, t(34)= 0.193, p = 
0.85.  
 
Table 3. Episodic Memory and Executive Functioning in Dependent Cannabis, Non-
Dependent Cannabis and Control Groups  
 
 Dependent 
Cannabis Users 
(n = 18) 
Non-
Dependent 
Cannabis Users 
(n = 18) 
 
Controls 
(n = 18) 
M (SD) M (SD) M (SD) 
Episodic memory:       
  Story recall – immediate 7.3 (2.5) 7.5 (2.7)  8.9 (3.1) 
  Story recall – delayed 6.5 (2.2) 6.3 (2.4) 7.6 (3.2) 
Executive functioning:       
  Phonemic fluency – letter 14.8 (5.8) 12.0 (3.7) 15.1 (4.5) 
  Category fluency – 
‘vegetables’ 15.6 (5.1)  13.6 (4.6) 15.9 (4.6) 
  Category fluency – ‘alcohol’ 20.5 (7.6) 19.3 (4.9) 21.7 (8.8) 
  Category fluency – 
‘cannabis’ 20.8 (7.8) 21.3 (7.7) - 
 
Depression, Anxiety and Schizotypy (Table 4; Figure 4) 
 There were group differences in depression, anxiety and schizotypy as 
measured by the BDI-II, F(2, 51) = 15.6, p<0.001, BAI, F(2, 51) = 9.89, p<0.001, and 
O-LIFE Unusual Experiences, F(2, 51) = 11.65, p<0.001. Bonferroni-adjusted 
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pairwise comparisons and p-values for each ANOVA indicated that the dependent 
cannabis group had significantly higher levels of depression, anxiety and schizotypy 
than both the non-dependent group (p <0.001; p <0.001; p = 0.001) and controls (p = 
0.001; p = 0.006; p <0.001). The control group and non-dependent group did not 
significantly differ on depression (p = 0.28), anxiety (p = 1.0) or schizotypy (p = 1.0). 
Cronbach’s alpha indicated high internal consistency for the BAI (α = 0.8), BDI-II (α 
= 0.87) and O-Life Unusual Experiences (α = 0.89).  
 
Table 4. Depression, Anxiety and Schizotypy in Dependent Cannabis, Non-Dependent 
Cannabis and Control Groups  
 
 Dependent 
Cannabis 
Users 
(n = 18) 
Non-
Dependent 
Cannabis 
Users 
(n = 18) 
 
Controls 
(n = 18) 
M (SD) M (SD) M (SD) 
Depression:       
  BDI-II Total Score*** 11.2 (4.9) 2.9 (3.6) 5.5 (5.1) 
Anxiety:       
  BAI Total Score*** 9.9 (6.3) 3.0 (3.6) 4.6 (4.5) 
Schizotypy:       
  O-LIFE – Unusual   
  Experiences*** 5.1 (2.4) 2.1 (2.8) 1.6 (1.6) 
            Note: *** p <.001, ** p <.01, * p <.05 
 
Using the clinical cut-offs for depression on the BDI-II (Table 5), 94 percent 
(n = 17) of both the non-dependent cannabis and control participants scored in the 
‘minimal’ range and six percent (n = 1) scored within the ‘mild’ range of depression. 
In the dependent cannabis user group, 33% of individuals (n = 6) scored within the 
mild depression range, with the remaining 67% of the group (n = 12) scoring in the 
minimal range. A chi-squared test indicated the difference between groups was 
significant, χ² (2, N = 54) = 7.38, p = 0.026. None of the participants across the whole 
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sample scored ‘moderately’ (score of 20-28) or ‘severely’ depressed (score of 29 or 
over). 
 
Figure 4. Mean (SE) scores for the BDI-II (Depression), BAI (Anxiety) and O-Life 
Unusual Experiences (Schizotypy) in the Dependent Cannabis, Non-Dependent 
Cannabis and Control Groups  
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Table 5. Clinical Categories for Depression on the BDI-II across Dependent Cannabis, 
Non-Dependent Cannabis and Control Groups  
 
  Dependent 
Cannabis 
Users 
(n = 18) 
Non-
Dependent  
Cannabis 
Users 
(n = 18) 
 
Controls  
(n = 18) 
Score range Clinical 
Category 
n (%) n (%) n (%) 
0-13* Minimal 12 (66.7) 
 
17 (94.4) 17 (94.4) 
14-19* Mild 6 (33.3) 1 (5.6) 1 (5.6) 
Note: *** p <.001, ** p <.01, * p <.05 
 
Pre-FES Virtual Week (Table 6) 
 The data from the pre-FES VW days (i.e. the first two days administered, prior 
to the introduction of FES) were first analysed to assess any baseline group differences 
in PM performance. The dependent variable was the proportion of tasks that were 
completed correctly. A 2x2x3 repeated measures ANOVA with the within-subjects 
factors of task regularity (irregular, regular), task cue (event-based, time-based) and 
between-subjects factor of group (dependent cannabis, non-dependent cannabis, 
controls) was run. There was a significant main effect of task cue, F(1, 51) = 10.07, p 
= 0.003, with Bonferroni-adjusted pairwise comparisons indicating that the proportion 
of correct responses was greater on event-related tasks (M = 0.82, SD = 0.19) than 
time-related (M = 0.72, SD = 0.25).  
 There was no main effect of task regularity, F(1, 51) = 0.39, p = 0.845, or 
interaction effects between group and task cue, F(1, 51) = 1.07, p = 0.352, group and 
task regularity, F(1, 51) = 2.68, p = 0.078, cue and task regularity, F(1, 51) = 3.403, p 
= 0.071, or a three-way interaction between task regularity, task cue and group, F(1, 
51) = 0.093, p = 0.912.   
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Table 6. Comparison of Dependent Cannabis, Non-Dependent Cannabis and Control 
Groups on Mean (SD) Proportion of Irregular and Regular PM tasks Completed 
Correctly in the Pre-FES VW 
 
 
 
PM task 
Dependent 
Cannabis Users 
(n = 18) 
Non-Dependent 
Cannabis Users  
(n = 18) 
 
Controls 
(n = 18) 
 
 M (SD) M (SD) M (SD) 
Irregular:    
Event-based 0.82 (0.17) 0.86 (0.21) 0.85 (0.23) 
Time-based 0.61 (0.31) 0.78 (0.21) 0.69 (0.33) 
Regular:    
Event-based 0.88 (0.15) 0.74 (0.25) 0.75 (0.34) 
Time-based 0.76 (0.28) 0.72 (0.28) 0.72 (0.36) 
    
 
Virtual Week with FES   
 To assess the impact of FES on PM performance, the proportion of irregular 
VW tasks completed correctly before the introduction of FES was compared to the 
FES condition. This was done for event-based tasks and time-based tasks separately, 
with two 2x3 repeated measures ANOVAs with the within subject factors of imagining 
(no-FES, FES) and the between-subjects factor of group (dependent cannabis, non-
dependent cannabis, controls).  
 For event-based irregular tasks, there was no main effect of FES, F(1, 51) = 
1.98, p = 0.165, nor an interaction  between FES and group, F(1, 51) = 0.258, p = 
0.774.   Similarly, for time-based irregular tasks there was no main effect of FES, F(1, 
51) = 0.337, p = 0.564, nor an interaction  between FES and group, F(1, 51) = 0.861, 
p = 0.429.    
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Correlations (Table 7) 
An exploratory analysis looked at the extent to which cognitive variables were 
associated with intellectual functioning (Spot-the-Word score) and amount of cannabis 
use (grams per week). PM (overall proportion correct on the VW), episodic memory 
(immediate and delayed story recall) and executive functioning (average fluency 
score) were correlated with Spot-the-Word score for all groups, and also with amount 
of cannabis used for the cannabis groups.  
 
Table 7. Spearman’s rho Correlations between Spot-the-Word, Cannabis Use (Grams 
per Week) and Cognitive Measures across Dependent Cannabis, Non-Dependent 
Cannabis and Control Groups 
 
  Dependent Cannabis 
Users 
(n = 18) 
Non-Dependent 
Cannabis Users 
(n = 18) 
 
Controls 
(n = 18) 
  STW 
score 
Cannabis 
use  
(grams 
pw) 
STW 
score 
Cannabis 
use  
(grams 
pw) 
STW 
score 
Prospective 
memory: 
VW 
overall 
proportio
n correct 
 
0.02  
(p = 0.94) 
 
-0.19 
(p = 0.43) 
 
0.41 
 (p = 0.09) 
 
-0.01 
 (p = 0.97) 
0.54 
 (p = 0.06) 
 
Episodic 
memory: 
Story 
Recall: 
Immediate 
0.23  
(p = 0.37) 
-0.13  
(p = 0.61) 
 
0.69** 
(p = 0.002) 
 
-0.22 
 (p = 0.37) 
0.44 
 (p = 0.06) 
 Story 
Recall: 
Delayed 
0.57** 
(p = 0.01) 
 
-0.87  
(p = 0.73) 
0.60** 
(p = 0.008) 
 
-0.08  
(p = 0.74) 
 
0.51* 
 (p = 0.03) 
Executive 
function: 
Average 
fluency 
score 
0.43 
(p = 0.08) 
 
-0.16  
(p = 0.54) 
-0.29 
(p = 0.25) 
 
0.31 
 (p = 0.22) 
0.18  
(p = 0.49) 
 
            Note: *** p <.001, ** p <.01, * p <.05. STW = Spot-the-Word. pw= per week 
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Discussion 
 
This is the first study to examine PM (regular, irregular, time- and event-based) 
and the effects of FES on PM ability in dependent and non-dependent frequent 
cannabis users compared to non-using controls. The three groups were well-matched 
on key variables including age, premorbid intelligence, highest level of education and 
alcohol use. There were no differences between groups in PM ability. The introduction 
of an FES condition requiring participants to mentally rehearse tasks did not lead to 
improvements in PM scores. All groups scored similarly on other cognitive measures: 
episodic memory and executive functioning (fluency tasks). Dependent and non-
dependent cannabis users both primarily smoked high-potency skunk, and did not 
differ on other cannabis use variables such as amount smoked per week.   
Dependent cannabis users scored higher than non-dependent users and non-
using controls on depression, with 33 percent falling into the category for ‘mild 
depression’ on the BDI-II compared to just six percent in each of the other two groups. 
Dependent cannabis users also scored higher on anxiety and schizotypy (‘psychosis 
proneness’) than the non-dependent and control group.  
After finding no PM differences across groups, we wondered whether 
differences in intelligence may be offsetting impairments in PM. We therefore 
explored as a post-hoc analysis whether there were associations between premorbid 
intelligence and all cognitive measures (PM, episodic memory, executive function), 
compared to amount of cannabis use (grams per week) and cognitive measures. 
Correlations indicated there were no associations between cannabis use and cognitive 
measures for the dependent and non-dependent groups. Premorbid intelligence, 
however, was moderately positively correlated with delayed episodic memory score 
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across all three groups. For non-dependent users, there was a moderate positive 
correlation between premorbid intelligence and immediate episodic memory. In none 
of the groups did pre-morbid intelligence correlate with PM. Thus, a post-hoc 
hypothesis that intellectual functioning in the cannabis groups was driving PM ability 
was not evidenced by the data. 
 
Effects of Cannabis Use on Prospective Memory 
 Previous literature generally indicates that people who use cannabis perform 
more poorly on tasks of PM than those who do not use the drug, suggesting that use of 
cannabis leads to a deficit in the ability to enact planned future actions. A recent meta-
analysis of studies using objective (e.g. video-based) measures of PM found deficits 
in cannabis users for both irregular event and irregular time-based tasks (Platt, 2014). 
Our findings (across both irregular and regular PM) are not consistent with this, finding 
no differences between frequent dependent cannabis users, non-dependent users and 
controls. We can also compare our findings to recent studies with similar designs using 
the VW in alcohol dependence (Griffiths et al., 2012) and heavy drinkers (Platt et al., 
2016) which did find specific PM deficits.  
There may be several explanations for our findings. Firstly, there may indeed 
be no effect of frequent cannabis use on PM, in contrast to the relatively well-
established effects of cannabis use on retrospective memory processes. Indeed, our 
findings are consistent with the three studies of PM that used self-report rather than 
objective measures of PM performance (Bedi & Redman, 2008a; Rodgers et al., 2001; 
Rodgers et al., 2003). In addition, two (out of six) PM studies using objective 
assessments (Cutler et al., 2012; Gallagher et al., 2014) measuring irregular event-
based PM, and one (out of five) studies measuring irregular time-based PM also did 
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not find differences between cannabis users and control groups (Cuttler et al., 2012). 
Interpreting the mixed existing literature is difficult given the broad range of 
definitions of ‘cannabis user’ used for determining inclusion across studies, the 
different measures of PM used, and additional methodological weaknesses. However, 
it does appear that in our study, when carefully controlling for demographic factors 
and within our sample of self-selecting young adults, cannabis use does not seem to 
affect PM as measured by the VW task.  
Another explanation of our findings is that there may be an effect of cannabis 
use on PM, but that it was not detected in this study due to insufficient power, ceiling 
level performance, or validity issues in the VW task. The proportion of correct 
responses on the VW was relatively high across groups, especially on event-based 
irregular PM. However, similarly high scores were also found in the comparable 
studies in alcohol (Platt et al., 2016; Griffiths et al., 2012). Future studies might 
consider increasing the number of PM tasks and over a more extended (virtual) period, 
thus increasing the difficulty level which may elicit different performance across 
groups. In addition, none of the previously reported PM in cannabis studies have used 
the VW paradigm, which perhaps places different demands on executive processes. 
For example, when people are required to perform a task at a certain time or event on 
the game, they select the ‘Perform Task’ button and a series of options appear. The 
VW thus has prompts, rather than requiring the participant to freely recall and execute 
the relevant task. Given shortfalls in reporting of other PM measures, it is unclear 
whether the other tests of PM also do this.  
There is also questionable validity of the VW task in relation to real life PM, 
despite its psychometric properties (Rendell & Henry, 2009). Everyday PM requires 
an individual to perform intended actions over several hours or days, often with several 
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active intentions each with different levels of importance. The time aspect and 
complexity of the construct of PM is not captured by the Virtual Week, which assesses 
PM using a simple lab task with each virtual day lasting approximately 15 minutes and 
with tasks bearing potentially little relation to real-life PM in participants’ lives. 
Therefore, it could also be useful to conduct future research aiming to replicate the 
findings of the current study as indicated above, and to corroborate the findings with 
an ecologically-valid measure of PM over a longer time-lag. For example, in a PM 
task used in Marsh and colleagues’ study (1998) participants filled in activity sheets 
documenting their tasks for the upcoming week and the task importance on a 7-point 
scale. Participants returned one week later and recorded whether each plan had been 
completed, and reasons for not completing a task, which may give some insight into a 
more real-life PM over a longer time scale. The study findings would be strengthened 
by an additional measure of PM such as this. 
It is important to consider the characteristics of the sample used in our study 
when interpreting the results on PM. The participants were relatively high functioning 
and well-educated, with 50-61% of each group having at least one university degree. 
In addition, the cannabis groups did not exhibit episodic memory or executive 
impairment relative to the control group, which is not consistent with previous studies 
of frequent cannabis users (for a review see Curran et al., 2016). Some large cohort 
studies demonstrate that cannabis users have lower educational attainment and are 
more likely to leave school early (Lynskey, Coffey, Degenhardt, Carlin & Patton, 
2003).  
To test the hypothesis that our sample included a cognitively-able subgroup of 
cannabis users for whom the cognitive effects of using cannabis are less pronounced 
(or non-existent), we conducted post-hoc correlational analyses exploring whether 
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intellectual functioning was driving the PM ability in the cannabis groups. These did 
not confirm this idea. This is consistent with a large meta-analysis (Schoeler et al., 
2016) which found that years of education did not moderate the cognitive effects of 
cannabis, and another study finding no correlation between educational qualifications 
and PM (Reese & Cherry, 2002).  
Another hypothesis is that in previous studies of PM in cannabis users, groups 
may have been mismatched on years of education. A systematic review (Broyd, van 
Hell, Beale, Yucel & Solowij, 2016) of the effects of cannabinoids on cognition, which 
considered 105 studies, found that more than 50% of studies did not report IQ or years 
of education. However, where studies did match on IQ or controlled for differences 
between groups, impairments remained for immediate and delayed memory and verbal 
learning and memory (PM was not measured). We did find an association between 
premorbid intelligence and episodic memory in non-dependent users only. Of the 
studies into PM and cannabis reviewed in this paper, two did not report premorbid 
functioning or educational attainment (McHale & Hunt, 2008; Bartholomew et al., 
2010), one reported only premorbid functioning (Montgomery et al., 2012), two 
reported both and there were no differences between groups (Gallagher et al., 2014; 
Hadjiefthyvoulou et al., 2011), and the final two reported a measure of premorbid 
functioning and educational attainment but they were different between groups 
(Cuttler et al., 2012; Bedi & Redman, 2008). This is not consistent for the studies 
finding differences compared to those not, again complicating the interpretations of 
findings in the literature. It will be important that future studies measure these variables 
to ensure comparability between groups of users and controls.  
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Effects of Future Event Simulation on Prospective Memory 
There were no improvements in PM performance across dependent cannabis 
users, non-dependent cannabis users and control participants after the introduction of 
FES. Cognitive rehearsal for tasks has been shown to improve some aspects of VW 
performance in heavy drinkers and those acutely administered alcohol (Platt et al., 
2016; Paraskevaides et al., 2010), but not for those dependent on alcohol (Griffiths et 
al., 2012).  It may be that this cognitive rehearsal strategy did not have a benefit in our 
participants. However, since compliance with instructions or quality of the simulations 
was not assessed it is difficult to gauge the true impact of this strategy. We can link 
this to findings from Part 1 of this paper, a systematic review of cognitive remediation 
for substance-using populations, which found no conclusive evidence in support of the 
intervention. The previous studies using FES in the VW in substance use (Griffiths et 
al., 2012; Platt et al., 2016) asked participants questions about their strategy use (e.g. 
open questions about their strategies, and ratings of vividness of the imagery). These 
questions were not introduced in our study due to time-restrictions limiting the number 
of tasks in the testing session (as part of a joint project). In hindsight, however, a brief 
question about participants’ ability to carry out the FES and what strategy they used 
could have been useful to help interpret our findings. Platt and colleagues (2016) 
found no correlations between VW performance and the vividness ratings taken in 
their study, and point out that in FES participants are asked to imagine the future events 
set in their day-to-day life. However, these do not occur, rather an event card on the 
VW is a prompt which may require a different cue for task completion than in the 
imagined setting.  According to the constructive episodic simulation hypothesis, 
episodic memory combines the details of past experiences (e.g. objects, people and 
locations) to depict potential future events (Schacter et al., 2008). It could be that the 
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tasks on the VW have no direct relevance to participants’ episodic memories (e.g. 
‘telephoning Bill about babysitting’), rendering imagining the potential future event 
a difficult task.  
 
Cannabis Use and the Effects of Cannabis Use on Mental Health 
Cannabis use variables measured in this study did not differ between users 
classified as dependent on the drug and those non-dependent. We had predicted that 
dependent users would smoke the higher-THC concentrated skunk (which has been 
associated with more pronounced cognitive effects), and were thus surprised to find 
that 83 percent of dependent users and 94 percent of non-dependent users primarily 
smoked skunk. This may be because skunk is increasingly the most readily available 
form of cannabis (Hardwick & King, 2008; Curran et al., 2016), unlike some of the 
less potent forms such as hash which have lower levels of THC and higher levels of 
CBD. It is likely therefore that other factors are leading to dependency within our 
sample, rather than the type of cannabis used.  
The finding that dependent users scored higher on schizotypy, yet smoked 
equally potent cannabis as the non-dependent group, could indicate this subgroup are 
affected in a different way by their cannabis use. This dependent group may have a 
pre-existing reactivity to cannabis that renders them more prone to experiencing 
psychotic-like symptoms – or, indeed, these symptoms were pre-existing and the group 
were more vulnerable to becoming dependent on the drug after starting cannabis use.  
In line with previous evidence (Grant & Pickering, 1998; van der Pol et al., 
2013), we found that dependent cannabis users were more depressed and anxious than 
non-dependent users. Cannabis may be used to self-medicate depression and anxiety 
(Grant & Pickering, 1998), and perhaps if cannabis use is serving this function in 
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people who are exhibiting more symptomology, they are more likely to develop a 
dependence on the drug. We could also hypothesise that the group of frequent smokers 
who exhibit depression and anxiety symptomology worry more about their cannabis 
use and thus score on the SDS as dependent (e.g. questions in the SDS include: ‘Do 
you worry about your use of cannabis?’ and ‘Do you wish you could stop?’). Schoeler 
and colleagues (2016) found in a meta-regression that lower levels of depression 
attenuated the adverse effects of cannabis on memory (this was not the same for 
anxiety). It is interesting therefore that in our sample, the group with the highest levels 
of depression (dependent cannabis users) did not exhibit memory deficits.  If the study 
was repeated with a greater difficulty of tasks and PM load, it would be useful to see 
whether any relationship between depression symptomology and PM performance 
would be prevalent.  
It would also be useful to carry out a prospective longitudinal study to decipher 
whether higher levels of depression, anxiety and schizotypy precede or are followed 
by the initiation of frequent cannabis use in those who go on to develop a dependence.  
 
Methodological and Broader Considerations 
 A key strength of the study is that groups were well-matched on baseline 
variables (age, gender, highest level of education, and premorbid intelligence). 
Frequency of cannabis use was clearly defined (four or more days per week), unlike 
other studies in this field. We also examined the effect of dependency across cannabis 
users who were balanced for frequency of use.   
There are some limitations of the study to consider. The recorded amount of 
cannabis used by participants was self-reported, and some people had difficulties 
identifying how much they smoked. This was because cannabis tends to either be sold 
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as an ‘eighth’ (however, may not actually weight an eighth of an ounce) or per a certain 
cost (e.g. a £20 bag worth). Estimates in grams were therefore approximate. Similarly, 
healthy controls have been found to underestimate their alcohol use (Feunekes, van’t 
Veer, van Staveren & Kok, 1999) due to social desirability, which could have masked 
differences between controls and cannabis users on the VW.  
It is also important to consider the order of the VW tasks and nature of the FES 
condition. The ‘control’ days of the VW (without FES) always came first, followed by 
the ‘experimental’ condition (the two FES days). This was to remove any carry-over 
effects of the FES task. However, due to keeping this order the same, there could have 
been practise effects, although the lack of improvement between the control and 
experimental conditions does not necessarily support this. As mentioned above, we do 
not know the extent to which participants successfully carried out the FES task as 
instructed. If they were not carrying it out as planned, and encoding the tasks as they 
had during the first two VW days, that could explain the lack of improvement 
following the introduction of FES.  
We must be cautious about generalising beyond the population sample who 
participated in the study – a group of relatively well-educated university and publicly-
recruited young adults who frequently use cannabis (on average six days a week). We 
cannot assume the same results would be found in an older sample of frequent cannabis 
users. In addition, the study tested a sample of self-selecting cannabis users which 
could possibly be a more motivated group than the average frequent cannabis user.  
More broadly, it is important to consider the widespread use of memory aids 
that people commonly use to assist enacting intended future actions. One could argue 
there is less of a requirement for PM skills given the accessible and available aids in 
which to remind ourselves of tasks (e.g. paper diaries, calendars, phone reminders, and 
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phone diaries). It would be useful to investigate how the prevalent use of such aids is 
affecting the extent to which we require our cognitive PM abilities, and whether there 
are associations between memory aid use and PM performance in studies. 
Additionally, the implications for any differences in PM may be less detrimental given 
the alternative options for reminding ourselves of to-be-remembered tasks.  
 
Clinical Implications 
 The results of this study may be relevant when considering cognitive 
interventions for cannabis users. The findings would not support the use of cognitive 
rehearsal for improving PM task performance, or to assist users in improving their PM 
for applying addiction treatment strategies. However, it is important to note our sample 
of cannabis users were not accessing help for their cannabis use so the findings may 
not necessarily be applicable to samples in treatment for reducing their use. Our 
findings do fall in line with the review of the literature (Part 1 of this paper) which 
found no consistent evidence for the effect of cognitive remediation for cognitive 
deficits. However, it could be that as our sample did not have deficits, this was not 
applicable.  
 There are implications from our findings for assessing mental health in 
dependent frequent cannabis users. It is likely this group may need support for their 
depression and anxiety, and may be using cannabis to cope with symptomology 
(although causality was not established in this study). Cannabis users who present at 
addiction or GP services should be screened for their mental health and referred 
appropriately to their local services. It may be that by addressing their 
depression/anxiety, their cannabis use will not escalate to a point where it becomes 
problematic.  
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Conclusions 
 This study was the first to test frequent cannabis users (dependent and non-
dependent) on various forms of PM, and compare them to non-using controls. When 
carefully matched on demographic variables, we found no evidence for a PM deficit 
as measured by the VW in our sample of young adults, nor evidence that an imagining 
task has any further effect on performance. Future research should aim to explore 
whether increased task difficulty on the VW leads to any differences or a replication 
of findings in this paper, alongside a measure of real-life PM and a question about 
strategy use in FES.  
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Part 3: Critical Appraisal 
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Introduction 
 In this critical appraisal, I will reflect on the background context to choosing 
the research topic, and my experiences over various stages of the research process. I 
will consider the strengths of the study, and factors that assisted it running smoothly – 
notably, working alongside a project partner and team. I will also discuss some of the 
more challenging aspects of the research process, and expand on some of the 
limitations of the study methodology. I will finally consider future directions for 
cannabis and PM, and reflect on the wider social and political implications of research 
into substance use that have come to my attention during this process.   
 
Background Context to the Research 
Prior to starting the DClinPsy, during my Master of Science degree in 
Evidence-Based Social Intervention, I learnt the importance of conducting high-
quality research to best estimate the effects of intervening into social, community or 
mental health problems.  Using the skills acquired during this programme, I went on 
to work as a Research Assistant (RA) contributing to the development of NICE clinical 
guidelines for mental health disorders, and later as an RA on a clinical RCT. Although 
I had pre-doctoral experience in secondary research and working on a primary research 
trial, I had never planned and followed a clinically-relevant primary research project 
through from start to finish, so was excited to gain experience of this on the DClinPsy.  
Building upon an interest in addictions, which was the topic area of my MSc 
dissertation (a systematic review of parenting programmes for substance-misusing 
mothers; Braidwood, 2011) and after starting a first year DClinPsy placement in an 
NHS drug addiction service, I was drawn towards research in the UCL Clinical 
Psychopharmacology Unit. Drug misuse and its costs - to the individual, their families 
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and communities - is a major challenge to the modern world, and I heard first-hand the 
stories from patients about the effects of their chronic drug use, which often started in 
the context of very traumatic histories.  
I decided to explore my interest into the effects of substance use by researching 
an aspect of cognition - prospective memory (PM) - in frequent cannabis users, and 
the effects of future event simulation (FES) as a technique for improving PM. A fellow 
trainee, Samantha Mansell, also expressed interest in future memory processes in 
cannabis users, so we decided to collaborate and undertake a joint research project. As 
our supervisors pointed out, research is rarely undertaken by a single person and there 
are great benefits of discussing ideas and problem solving as a team, so I was excited 
to be part of a joint project.  
 
Planning, Recruitment and Testing 
Two previous DClinPsy trainees (with support from the UCL Clinical 
Psychopharmacology Unit) had explored PM and future event simulation in alcohol 
use (Griffiths, Hill, Morgan, Rendell, Karimi, Wanagaratne & Curran, 2012; Platt, 
Kamboj, Italiano, Rendell, & Curran, 2016). The effects of frequent cannabis on PM 
in were yet to be explored, and we aimed to carry out a study using the same objective 
measure of PM (the Virtual Week) to allow for direct comparison.  
After several months of reading around the topic, discussing the proposed ideas 
with our supervisors, the Clinical Psychopharmacology Unit team, and my project 
partner, the measures and finer details of the study were set out. During this process, 
we researched into drug dependency and decided to recruit both dependent and non-
dependent cannabis users. We made decisions about categorisation, e.g. that four days 
a week would count as ‘frequent’ use as it denotes more days smoking a week than 
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not, and as frequency of use rather than amount of use per se that is linked to increase 
chance of dependency (Curran et al., submitted). Although these initial decisions were 
ground in the literature and discussed with the team, I felt a sense of responsibility in 
making the ‘right’ decisions and wanting to state very explicitly our inclusion criteria 
prior to recruitment in order to reduce bias and indecision upon assessing each 
potential participant. My confidence grew in making such decisions (e.g. about study 
inclusion) with practice and directly referring to our criteria.  
Throughout the early stages of setting up the research project, I really felt the 
benefits of planning with a team rather than as an individual; it helped us to question, 
justify, bounce new ideas off each other and make decisions. As the Clinical 
Psychopharmacology Unit already had an ethics approval for ‘investigating the 
determinants and psychological consequences of ketamine and high-potency cannabis 
use’, we submitted an amendment to the existing submission with the details of our 
study. This was approved shortly after it was sent (one week later), and thus ethics 
approval was rather straightforward in this study.  
The next stage of the research process was recruitment and testing; Samantha 
and I enlisted help from an MSc student Jon Waldron to assist us with this. In carrying 
out a joint research project, and with the support from Jon, we were able to increase 
our sample size to far greater than would have been possible if we had worked as 
individuals, as the workload of testing was shared. Working as a three, we set ourselves 
deadlines and goals for testing and together planed our recruitment initiatives. We 
helped to motivate each other, often simultaneously testing participants in the same 
slots in separate rooms, so we could set up together and debrief. We also were aware 
of the importance of consistency of testing sessions, so prepared a detailed script to 
the testing session that we all followed, and of being organised with our materials to 
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ensure we had the right order of measures for each participant’s counterbalanced 
condition. We observed each other during the pilot period, where we each piloted one 
participant with the others in the room, again to ensure consistency.  
I have reflected on how living in an age of social media and the internet made 
our recruitment a much easier process; when we re-posted our advert on social media 
or enlisted a new website for the advert (e.g. introduced an advert on Gumtree, half-
way through recruiting after a brief lull in interest), we got a surge of new emails from 
potential participants. We also used more traditional methods such as handing out 
flyers and putting up adverts, on university noticeboards and in some public spaces 
(such as Camden Lock and a ‘4-20’ cannabis event in Hyde Park). We did not struggle 
with recruitment, and our recruitment drives and flexibility (such as working some 
evenings and weekends, and having three potential testers’ availability to work with) 
aided the process. There were, however, a few challenges during the testing period. 
Several participants cancelled at the very last minute, or did not show up, which was 
frustrating as it meant a time-slot was lost. After this, aside from the confirmation 
email we sent out when participants agreed to attend a slot, we introduced a second 
reminder on the evening before or morning of their testing session, which seemed to 
have an impact on attendance rates and more notice of cancellation if they were not 
going to attend.  
Our efforts to match participants on age, gender, alcohol consumption and 
highest level of education meant that towards the end of the recruitment process we 
had to actively seek participants (e.g. low-alcohol consuming, less-educated controls) 
and screen more people to find participants that fit our criteria. Also, we found that 
more of the cannabis participants that we screened were non-dependent according to 
our criteria, and so we had to turn away otherwise eligible non-dependent users who 
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we screened during the latter stages of recruitment and wait for dependent users to 
come forward. Given that we started testing participants ahead of schedule, the 
cancellations and more screenings we had to carry out for matched-participants did not 
majorly delay our study progress.  
We also gained useful qualitative information about participants during the 
testing sessions, in informal conversations when walking them in and out of the 
building. A few spoke passionately about their use of cannabis, and wanted to actively 
participate in research to ‘prove’ that cannabis was not associated with adverse effects. 
I wondered if our participants represented a sample of cannabis users who were 
motivated and keen to contribute to research, but may not, potentially, be 
representative of other users who are less so. This is hard to overcome in studies with 
self-selecting participants, and it would be interesting to see what a similar study 
carried out in a clinical setting, where people are seeking help for their drug use, would 
find.  
 
Limitations and Future Directions 
If the study were to be repeated, a question about use of strategy in FES would 
be an important addition. We cannot assume from the data as it stands that FES as a 
technique when carried out as intended has no effect on performance, as we do not 
know what participants were carrying out during the 10-seconds where they were 
instructed to imagine the task context, and how they were doing it (e.g. visually 
imagining the context, or repeating the words).  A challenge of being part of a joint 
research project was the length of our testing session, which was already two and a 
half hours, and thus some additional ideas for measures were cut. However, in 
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hindsight, this was important and would have been included if we were to re-run the 
study.  
As indicated in the empirical paper, another limitation of the Virtual Week is 
that the ‘perform task’ button which is available on the board for the duration of the 
game presents participants with several options of tasks to carry out. There is a chance 
that participants looked at this feature to remind themselves of upcoming tasks, serving 
as a prompt, before they necessarily had the intention of performing a task. This would 
of course confound the results, if some participants used this feature (as more of a 
prospective recognition rather than recall task), whereas others may have not paid it 
attention. It could be argued that this potential recognition element resembles real-life 
PM in that people so often use diaries and calendars to prompt their memory, where 
they are met with their list of tasks or plans. It would be interesting to see how the 
results differed (if at all) if participants had to type the task which was required of them 
at the appropriate point in the game, without a task list presented, thus removing any 
potential for uncontrolled prompting. 
A few of the minor study task and event card details were changed from the 
original Virtual Week version that we used, such as food choices for lunch, which were 
changed to suit a British sample than Australian, where the programme was developed. 
However, it is questionable how applicable the tasks in general and finer details (e.g. 
names of people in the game) were to the participants’ lives, and thus whether they 
were able to generate images of themselves performing such tasks. Also, given the age 
range of our sample (average age of 24 years), perhaps task selection relevant to this 
age would have rendered the measure of PM and use of FES more applicable. It is also 
important to consider that FES is hypothesized to work by formation of a mental 
representation of the context in which the task is to be completed which prompts task 
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completion when that context is later encountered (Paraskevaides et al., 2010). In the 
board game, however, tasks are presented in the form of words, as are later cues to 
task completion (i.e. event cards), yet FES requires a visual representation. It may be 
questioned, then, whether the visual context imagined during FES is appropriately later 
triggered when encountering the related event card.  
As already indicated, given the relatively high proportion of correct responses 
on the Virtual Week across all groups, it would be useful to repeat the study with a 
greater task load and perhaps for more virtual days, to see if the similarity in 
performance across groups remains when the cognitive load and difficulty is higher. 
In addition, it would be interesting to carry out the study on a clinically-dependent 
sample who were seeking help for their cannabis use, compared to our samples who 
were not in treatment but were identified as dependent from a brief screening measure. 
Results in a clinical setting would have more relevance and applicability to clinical 
samples. 
Finally, when reflecting on how the sample in the study relates to the patients 
I have seen in my addiction placement (and in my Early Intervention for Psychosis 
service, where a number of patients I was working with had a history of cannabis use), 
I have considered ethnicity. An important omission to our study was not recording 
ethnicity, especially when we are considering whether our sample was a representative 
sample and whether we can generalize the results to the real population.   
 
Wider Implications and Reflections  
 During and after carrying out this study, I have considered wider issues such 
as the political implications around researching into drugs, and the importance of 
publishing studies that find no differences between groups (or no effects of 
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interventions) in research more generally. This first came to light when screening 
participants for the study, where a few individuals questioned whether it was safe for 
them to participate anonymously given they were using an illegal drug and checking 
that their name would not be held or used against them.  
Despite the prevalence of drug use worldwide and consequent importance of 
researching the effects, the area is complicated by politics due to the illegality of most 
drugs, and political stances against changing policy in line with evidence if it comes 
contrary to existing beliefs or supposed public opinion. The government’s chief drug 
advisor and scientist Professor David Nutt was sacked by the home secretary in 2009 
after a publishing a classification of harms and consequent ranking of drugs based on 
this (Nutt, 2009) which indicated that alcohol and tobacco were more harmful than 
many illegal drugs (including ecstasy and cannabis). Coming from an evidence-based 
background and perspective, I believe it is highly important that research into drugs is 
well-conducted, published, and used to inform policy and peoples’ decisions. Given 
that this current study finds there was no differences between cannabis users and 
control participants, the political implications seem especially relevant. It is also 
important all well-conducted study findings are published in scientific journals or 
widely available, as we know that the literature is biased towards publishing studies 
that find effects rather than non-effects (Winters & Wier, 2017). We can only best 
assess the effects of an intervention, or in this case the effects of a substance, if we 
have all the existing evidence available to us to pool together. Carrying out this 
research has reminded me of the importance of publishing research, especially 
persisting in doing so if journals reject a paper which does not show an effect between 
groups.  
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Conclusions 
 In summary, I have genuinely found each stage of this research project (such 
as planning, recruiting, testing, analysing and interpreting the results) a really 
enjoyable process. There are some key strengths to the study, as mentioned, as well as 
improvements and suggestions for future research. I have learnt skills which I will 
certainly take beyond the DClinPsy course and into my future career as a Clinical 
Psychologist, where I hope to actively contribute to clinically-related research and to 
share the findings regardless of the direction of the results. I have really valued 
working as part of a small team during the earlier stages of the research project, and 
have greatly appreciated the support throughout from both of my supervisors Professor 
Valerie Curran and Dr Sunjeev Kamboj, as well as the rest of their team. 
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Appendix 1. Search Strategy 
1. exp Cognitive Rehabilitation/ 
2. exp Brain Training/ 
3. (cognit* adj2 stimulation).ti,ab. 
4. (cognit* adj2 rehabilitation).ti,ab. 
5. (cognit* adj2 remediation).ti,ab. 
6. (cognit* adj2 training).ti,ab. 
7. (cognit* adj2 retraining).ti,ab. 
8. (cognit* adj2 enhancement).ti,ab. 
9. (cognit* adj2 support).ti,ab. 
10. exp "SUBSTANCE ABUSE AND ADDICTION MEASURES"/ or exp 
"SUBSTANCE USE DISORDER"/ 
11. exp Drug Dependency/ or exp Drug Rehabilitation/ or exp Drug Addiction/ or 
exp Drug Abuse/ or exp Addiction/ or exp Alcoholism/ or exp Alcohol Abuse/ 
12. (drug adj2 abuse).ti,ab. 
13. (abuser* or abusing or addict* or depend* or habit* or misuse or user*).mp. 
[mp=title, abstract, heading word, table of contents, key concepts, original title, 
tests & measures] 
14. (abuse not (child* or sex*)).mp. [mp=title, abstract, heading word, table of 
contents, key concepts, original title, tests & measures] 
15. (adinazolam or alcohol* or alprazolam or amphetamin* or analgesic or 
anaesthetic or anthramycin or anxiolytic* or ativan or barbituat* or 
bentazepam or benzodiazepin* or bromazepan or brotizolam or buprenorphin* 
or camazepam or cannabi* or chlordiazepoxid* or cinolazepam or clobazam 
or clonazepam or clorazepam or clotiazepam or cloxazolam or cocaine* or 
codeine or crack or crystal or cyprazepam or depressant* or diacetylmorphin* 
or diazepam* or doxefazepam or estazolam or etizolam or fentanyl or 
flunitrazepam or flurazepam or flutazoram or flutoprazepam or fosazepam or 
GHB or girisopam or halazepam or hallucinogen* or haloxazepam or heroin* 
or hydrocodone or hydromorphone or hydroquinone or hypnotic* or inhalant* 
or ketamin* or ketazolam or librium or loflazepate or loprazolam or lorazepam 
or lormetazepam or marihuana* or marijuana* or meclonazepam or 
medazepam or meperidine or mephedrone or mescalin* or metaclazepam or 
methadone or methamphetamin* or methaqualone or mexazolam or 
midazepam or midazolam or morphine* or narcotic* or nerisopam or 
nimetazepam or nitrazepam or nitrites or (nitrous adj oxide) or nordazepam or 
opiate* or opiod* or opium or oxazepam or oxazolam or oxazypam or 
oxycodone or oxycontin or oxzepam or painkiller* or (pain adj killer*) or PCP 
or pethidin* or Percocet or phencyclidin* or pinasepam or poly* or prazepam 
or propazepam or propoxyphene or psychoactive* or psychostimulant* or 
quinazolinone or ripazepam or ritalin or sedative* or serazepin* or solvent* or 
stimulant* or substance* or temazepam or tetrazepam or tofisopam or tramadol 
or triazolam or triflubazam or valium or vicodin).mp. [mp=title, abstract, 
heading word, table of contents, key concepts, original title, tests & measures] 
16. exp Relapse Prevention/ 
17. (relapse adj prevent*).mp. [mp=title, abstract, heading word, table of contents, 
key concepts, original title, tests & measures] 
18. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 16 or 17 
19. 10 or 11 or 12 
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20. (13 or 14) and 15 
21. 19 or 20 
22. 18 and 21 
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Appendix 2. Risk of Bias Tables 
 
Bell et al. (2016) 
 
Bias Authors’ 
judgement 
 
Support for judgement 
Random sequence 
generation 
(selection bias) 
 
Low risk Block randomisation of six performed by 
independent statistician 
Allocation 
concealment 
(selection bias) 
 
Unclear 
risk 
No allocation concealment procedures were 
described 
Incomplete 
outcome data 
(attrition bias) 
All outcomes 
Low risk 3 patients were excluded from the analysis 
(out of 34): 1 in CCT group, 2 from WT 
group. One withdrew after randomisation 
before starting the intervention (not reported 
which group), one patient due to 
hospitalisation and one declined the PT 
testing as he was employed. 2 more 
participants were lost at 6 month FU, last 
observation carried forward used in 
analysis. Low risk due to low attrition 
 
Selective reporting 
(reporting bias) 
High risk Protocol registered NCT01410110.  Author 
sent some additional outcomes after 
correspondence; not all measured were 
reported in the publication (days of sobriety; 
alcohol use) 
 
Blinding of 
participants and 
personnel 
(performance bias) 
All outcomes 
 
High risk Participants and personnel would have been 
aware of group condition 
Blinding of 
outcome 
assessment 
(detection bias) 
All outcomes 
 
High risk ‘Assessments were performed by…. this 
person was not blind to participant 
condition’ 
Other bias Low risk No other significant sources of bias were 
identified 
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Czuchry & Dansereau (2003) 
 
Bias Authors’ 
judgement 
 
Support for judgement 
Random sequence 
generation 
(selection bias) 
Unclear 
risk 
Communities were “randomly assigned”. 
No details of how random sequence was 
generated 
 
Allocation 
concealment 
(selection bias) 
Unclear 
risk 
No reporting of how allocation was 
concealed prior to assignment 
 
Incomplete 
outcome data 
(attrition bias) 
All outcomes 
Unclear 
risk 
Dropout was not reported, nor how any 
(potential) missing data was analysed. Ns 
used in analyses not provided 
 
Selective 
reporting 
(reporting bias) 
 
Unclear 
risk 
No protocol registered. Results for all stated 
outcomes reported although not all raw 
scores not given 
Blinding of 
participants and 
personnel 
(performance 
bias) 
All outcomes 
High risk Participants and personnel would have been 
aware of their condition 
Blinding of 
outcome 
assessment 
(detection bias) 
All outcomes 
Unclear 
risk 
Counsellors and an on-site research assistant 
administered all measures. It is likely they 
would have not been blind to community 
condition, although this is not reported 
 
Other bias Unclear 
risk 
Depending on whether the counsellors and 
peers were blind (likely not), there may 
have been additional bias in the results from 
the peer and counsellor outcome ratings 
 
Fals-Stewart & Lucente (1994) 
 
Bias Authors’ 
judgement 
 
Support for judgement 
Random sequence 
generation 
(selection bias) 
 
Unclear 
risk 
‘Randomly assigned’. No details of 
randomisation procedure i.e. how the 
sequence was generated 
Allocation 
concealment 
(selection bias) 
 
Unclear 
risk 
No allocation concealment procedures were 
described 
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Incomplete 
outcome data 
(attrition bias) 
All outcomes 
Low risk Relatively low and evenly spread attrition: 8 
subjects did not complete the study (2 in 
each group) and were not included in the 
analysis 
 
Selective reporting 
(reporting bias) 
 
Unclear 
risk 
No protocol registered 
Blinding of 
participants and 
personnel 
(performance bias) 
All outcomes 
High risk ‘Staff and patients were told that the study 
was designed to determine the effect of the 
different interventions on participants’ 
neuropsychological test performance. They 
were not told any a priori hypotheses.’ 
However, due to the nature of the 
intervention, participants would have been 
aware of which intervention they were 
receiving 
 
Blinding of 
outcome 
assessment 
(detection bias) 
All outcomes 
Unclear 
risk 
It is not reported whether research 
psychometrician who administered the 
neuropsychological battery was blind. 
Clinical staff who rated patients with the 
SRS were unaware of research hypotheses 
however it is now reported whether they 
were aware of group assignment 
 
Other bias Low risk No other potential biases identified 
 
Fals-Stewart & Lam (2010) 
 
Bias Authors’ 
judgement 
 
Support for judgement 
Random sequence 
generation 
(selection bias) 
Low risk ‘The presence of cognitive impairment … 
was used in a covariate-adaptive urn 
randomisation procedure’ 
 
Allocation 
concealment 
(selection bias) 
Unclear risk No description of how the allocation was 
concealed. Randomisation occurred after 
baseline interviews 
 
Incomplete 
outcome data 
(attrition bias) 
All outcomes 
Low risk There was a reasonable level of attrition: at 
PT, 5/80 patients in CACR group & 8/80 in 
CATT group did not complete outcome 
measures. Some missing data at follow up: 3 
month (CACR N=75, CATT N=72), 6 month 
(CACR N=74, CATT N=72), 9 month 
(CACR N=70, CATT N=69), 12 month 
(CACR N=72, CATT N=73). Multiple 
imputation (MI) methods were used; multiple 
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data sets were generate and analyses of 
separate datasets were then combined 
Selective 
reporting 
(reporting bias) 
Unclear risk No trial protocol. All outcomes specified in 
the paper were reported, although not all raw 
scores presented 
 
Blinding of 
participants and 
personnel 
(performance 
bias) 
All outcomes 
 
High risk Participants and personnel would have been 
aware of their condition 
Blinding of 
outcome 
assessment 
(detection bias) 
All outcomes 
 
Low risk Research assistants ‘who remained unaware 
of randomisation assignment’ conducted all 
baseline and post-treatment interviews 
Other bias Low risk No other significant sources of bias were 
identified 
 
Gamito et al. (2014) 
 
Bias Authors’ 
judgement 
 
Support for judgement 
Random sequence 
generation 
(selection bias) 
 
Low risk Simple randomisation with a random 
number generator 
Allocation 
concealment 
(selection bias) 
Unclear risk No reporting of how allocation was 
concealed prior to assignment. From the 
paper’s attached CONSORT-EHEALTH 
Checklist V1.6.2 Report: “not applicable”. 
Author’s reply to email (4/1/17) did not 
clarify: ‘Allocations were determined by 
random assignments of patients to each of 
the groups’ 
 
Incomplete 
outcome data 
(attrition bias) 
All outcomes 
High risk 14/68 patients dropped out of the study (7 
from each group). Missing data was not 
imputed- it was excluded from the analysis 
 
Selective 
reporting 
(reporting bias) 
High risk Trial registered NCT01942954. Protocol 
states aside from the FAB which is reported 
in the paper, participants would be assessed 
in “Frontal Lobe Cognitive Functioning 
(Retention, Attention and Calculation, 
Language and Visual-spatial abilities)” – but 
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does not state using which measures. The 
paper reports ‘cognitive flexibility’ (WCST) 
and the Color Trail Test (CTT). When asked 
in email to the author, the reply (4/1/17): 
“The cognitive domains related to Retention, 
Attention and Calculation, Language and 
Visual-spatial abilities are categories of the 
Mini-Mental State Examination test and 
were not assessed in our paper. We mention 
these domains when describing the measure, 
but were not assessed because it was not our 
main aim” 
 
Blinding of 
participants and 
personnel 
(performance 
bias) 
All outcomes 
High risk Patients and personnel were not blind to 
their condition, knowing which was the 
intervention of interest and the comparator 
 
Blinding of 
outcome 
assessment 
(detection bias) 
All outcomes 
Low risk From CONSORT-EHEALTH Checklist 
V1.6.2 Report: “outcome assessors were 
blind to the experimental group of the 
participants” 
 
Other bias Low risk No other potential biases identified 
 
Goldman & Goldman (1987) 
 
Bias Authors’ 
judgement 
 
Support for judgement 
Random sequence 
generation 
(selection bias) 
Unclear risk ‘Each alcoholic subject was randomly 
assigned’. No details of the method used to 
generate the allocation sequence given. 
 
Allocation 
concealment 
(selection bias) 
Unclear risk No allocation concealment procedures 
were described 
Incomplete 
outcome data 
(attrition bias) 
All outcomes 
Unclear risk Attrition was not reported nor were the 
numbers randomised or subsequently 
analysed in each intervention group 
 
Selective 
reporting 
(reporting bias) 
Unclear risk No protocol. All stated outcomes discussed 
but means/SDs/Ns in analyses not reported 
 
Blinding of 
participants and 
personnel 
(performance 
High risk Participants and personnel would have 
been aware of their intervention condition 
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bias) 
All outcomes 
 
Blinding of 
outcome 
assessment 
(detection bias) 
All outcomes 
 
Unclear risk Blinding of outcome assessors was not 
reported 
Other bias Low risk No other potential biases identified 
 
Grohman & Fals-Stewart (2003) 
 
Bias Authors’ 
judgement 
 
Support for judgement 
Random 
sequence 
generation 
(selection bias) 
Unclear risk ‘Randomly assigned’ after baseline 
assessment. No details of the method used to 
generate the allocation sequence given 
 
Allocation 
concealment 
(selection bias) 
 
Unclear risk No allocation concealment procedures were 
described 
Incomplete 
outcome data 
(attrition bias) 
All outcomes 
Unclear risk Dropout of the intervention during treatment 
stay was not reported explicitly. Could 
assume there was no dropout as under 
‘Procedure’ reports participants engaged in 
the respective exercises 3 times weekly for 50 
minutes, ‘all of these participants were guided 
through the intervention in each of these 
conditions by a research assistant to ensure 
that the tasks were completed’ 
 
Selective 
reporting 
(reporting bias) 
Unclear risk No protocol registered. All specified 
measures in the paper are reported. Only 
measured cognitive functioning at baseline 
 
Blinding of 
participants and 
personnel 
(performance 
bias) 
All outcomes 
 
High risk Participants and personnel knew which 
intervention group they were in 
Blinding of 
outcome 
assessment 
(detection bias) 
All outcomes 
Unclear risk Not reported. However, outcome measures 
were all objective (length of stay in treatment; 
reason for discharge) so blinding not 
necessarily appropriate 
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Other bias Low risk None identified 
 
Mathai et al. (1998) 
 
Bias Authors’ 
judgement 
 
Support for judgement 
Random 
sequence 
generation 
(selection bias) 
Unclear risk ‘Allocated at random’. No description of how 
the randomisation sequence was generated was 
given 
 
Allocation 
concealment 
(selection bias) 
 
Unclear risk No allocation concealment procedures were 
described 
Incomplete 
outcome data 
(attrition bias) 
All outcomes 
Low risk 1 patient in the control group ‘went to his 
native town after the pre-assessment and came 
only for the post assessment’. No other mention 
of incomplete outcome data. 1 person lost to 
FU 
 
Selective 
reporting 
(reporting bias) 
Unclear risk No protocol. Means and SDs reported for 
outcomes identified in the paper 
 
Blinding of 
participants and 
personnel 
(performance 
bias) 
All outcomes 
 
High risk Participants and personnel would have been 
aware of their treatment condition 
Blinding of 
outcome 
assessment 
(detection bias) 
All outcomes 
 
Unclear risk Whether outcome assessors were blind was not 
reported in the paper 
Other bias High risk Treatment group were ‘counselled more 
frequently’ than TAU group [therefore limiting 
difference between groups as only the presence 
of the cognitive intervention] 
Small overall sample size: N=8 
 
Rass et al. (2015) 
 
Bias Authors’ 
judgement 
 
Support for judgement 
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Random 
sequence 
generation 
(selection bias) 
Low risk Participants were randomly assigned using a 
‘minimisation procedure’ to balance groups on 
various parameters 
 
Allocation 
concealment 
(selection bias) 
Unclear risk Not reported. Restricted randomisation 
(minimisation) increases chance of selection bias 
if next allocation can be predicted with greater 
than 50% probability. Author emailed but did 
not answer questions, just referred back to the 
paper where it was not clear 
 
Incomplete 
outcome data 
(attrition bias) 
All outcomes 
High risk 9/37 dropped out of CCRT and 8/38 from ACC 
group. Only treatment completers were included 
in analysis – dropouts excluded. High level of 
attrition 
 
Selective 
reporting 
(reporting bias) 
High risk Trial registered on clinicaltrials.gov: 
NCT01271413. Several outcomes assessed (as 
reported in the paper, e.g. operation span task, 
visuo-spatial working memory task) were not 
pre-specified in the protocol.  Author emailed 
regarding these but did not answer questions, 
just referred back to the paper where it was not 
clear 
 
Blinding of 
participants and 
personnel 
(performance 
bias) 
All outcomes 
 
High risk Participants and personnel were aware of their 
intervention allocation 
Blinding of 
outcome 
assessment 
(detection bias) 
All outcomes 
 
Low risk Pre- and post-training assessment sessions were 
administered by a research assistant blind to 
training condition, ‘with one exception due to 
error’ 
Other bias Low risk No other biases identified 
 
Roehrich & Goldman (1993) 
 
Bias Authors’ 
judgement 
 
Support for judgement 
Random sequence 
generation 
(selection bias) 
Unclear risk ‘Each participant was randomly assigned’, 
‘subjects younger than 40 years and those 
40 years of age and older were assigned 
separately to each group to balance for age 
both within and across groups’. No 
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description of what method used to do this 
randomly 
 
Allocation 
concealment 
(selection bias) 
 
Unclear risk No allocation concealment procedures 
were described 
Incomplete 
outcome data 
(attrition bias) 
All outcomes 
 
Low risk Drop out not reported. The N’s in the 
analysis reported are the same as the Ns 
randomised so can assume there was no 
dropout or scores were imputed 
Selective 
reporting 
(reporting bias) 
Unclear risk No protocol. All outcomes specified in 
paper were reported in means/SDs 
 
Blinding of 
participants and 
personnel 
(performance 
bias) 
All outcomes 
 
High risk Participants and personnel would not be 
blind to intervention received 
Blinding of 
outcome 
assessment 
(detection bias) 
All outcomes 
 
Unclear risk Blinding of outcome assessors was not 
reported 
Other bias Low risk No other biases identified. 
 
Rupp et al. (2012) 
 
Bias Authors’ 
judgement 
 
Support for judgement 
Random 
sequence 
generation 
(selection bias) 
Unclear risk ‘Randomly assigned’. No details of 
randomisation procedure reported. Author 
emailed but no reply received 
 
Allocation 
concealment 
(selection bias) 
 
Unclear risk No allocation concealment procedures were 
described. Author emailed but no reply 
received 
 
Incomplete 
outcome data 
(attrition bias) 
All outcomes 
High risk Of the 45 randomised, 4 were excluded prior 
to starting the intervention as they did not 
show a mild cognitive deficit. From the 41 
who made up the sample, 0 patients in the 
CR group and 4 in the CG did not provide 
post-treatment data [1 was discharged from 
inpatient treatment for drinking alcohol, 3 
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terminated treatment prematurely]. Ns are 
not provided in the Results tables so 
unknown whether data was imputed or 
excluded 
 
Selective 
reporting 
(reporting bias) 
Unclear risk No known protocol. All specified outcome 
measures in the paper reported (means/SDs) 
but not with Ns used in analyses. Author 
emailed but no reply received 
 
Blinding of 
participants and 
personnel 
(performance 
bias) 
All outcomes 
 
High risk Participants and personnel would have been 
aware of their group allocation by nature of 
the interventions 
Blinding of 
outcome 
assessment 
(detection bias) 
All outcomes 
 
Unclear risk Whether outcome assessors were blind to 
group was not reported. Author emailed but 
no reply received. 
Other bias Low risk No other biases identified 
 
Steingass et al. (1994) 
 
Bias Authors’ 
judgement 
 
Support for judgement 
Random 
sequence 
generation 
(selection bias) 
Unclear risk Participants were ‘randomly assigned’. How 
the randomisation sequence was generated 
or the participants randomly assigned was 
not reported 
 
Allocation 
concealment 
(selection bias) 
Unclear risk No reporting of how allocation was 
concealed prior to assignment 
 
Incomplete 
outcome data 
(attrition bias) 
All outcomes 
Unclear risk 6 participants prior to 
assessment/intervention were excluded as 
they were illiterate. No mention of dropout 
apart from one subject failing to complete 
one outcome measure (D2 test), it was not 
reported whether data was imputed so likely 
to have been left out of analysis 
 
Selective 
reporting 
(reporting bias) 
Unclear risk No protocol. All specified outcomes 
reported (means and SDs) 
 
138 
 
Blinding of 
participants and 
personnel 
(performance 
bias) 
All outcomes 
 
High risk Participants and personnel would have been 
aware of their group allocation. 
Blinding of 
outcome 
assessment 
(detection bias) 
All outcomes 
 
Unclear risk It is not reported who carried out the 
outcome assessments and whether they were 
blind to condition. 
Other bias Low risk No other biases identified 
 
Stringer & Goldman (1998) 
 
Bias Authors’ 
judgement 
 
Support for judgement 
Random 
sequence 
generation 
(selection bias) 
Unclear risk ‘Randomly assigned’. No details of how 
randomisation was done are given 
 
Allocation 
concealment 
(selection bias) 
Unclear risk No reporting of how allocation was concealed 
prior to assignment 
 
Incomplete 
outcome data 
(attrition bias) 
All outcomes 
 
Unclear risk The actual Ns assigned to each group are not 
reported. No mention of attrition 
Selective 
reporting 
(reporting bias) 
Low risk No protocol. Means depicted for each group 
on a graph, no SDs for block design (specified 
outcome measure). 
Blinding of 
participants and 
personnel 
(performance 
bias) 
All outcomes 
 
High risk Participants and personnel would have been 
aware of their group assignment 
Blinding of 
outcome 
assessment 
(detection bias) 
All outcomes 
 
Unclear risk No mention of blind outcome assessors 
Other bias Low risk No other risks identified (but small N in each 
group -  ~10) 
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Wetzig & Hardin (1990) 
 
Bias Authors’ 
judgement 
 
Support for judgement 
Random 
sequence 
generation 
(selection bias) 
Unclear risk ‘Because of the possible biasing effects of 
variables such as race, age and education, 
subjects were matched on the basis on these 
demographics and then assigned randomly to 
each of the three groups’. No detail of how 
the groups were randomly assigned 
 
Allocation 
concealment 
(selection bias) 
 
Unclear risk No description of allocation concealment 
Incomplete 
outcome data 
(attrition bias) 
All outcomes 
 
Low risk No dropout is reported, although Ns in 
analysis are not reported 
Selective 
reporting 
(reporting bias) 
Unclear risk No protocol registered. Means and SDs 
provided for primary outcomes 
 
Blinding of 
participants and 
personnel 
(performance 
bias) 
All outcomes 
 
High risk Participants and personnel would have been 
aware of their group assignment 
Blinding of 
outcome 
assessment 
(detection bias) 
All outcomes 
 
Unclear risk Not reported whether outcome assessors were 
blind. 
Other bias Low risk None identified 
 
Yohman et al. (1988) 
 
Bias Authors’ 
judgement 
 
Support for judgement 
Random 
sequence 
generation 
(selection bias) 
Unclear risk ‘Groups of 3 to 7 alcoholic subjects from 
successive ward treatment groups were 
randomly assigned’. No details of how 
randomisation sequence was generated. Not 
individual randomisation 
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Allocation 
concealment 
(selection bias) 
Unclear risk Successive ward treatment groups were 
assigned. No mention of how which group 
they would fall in to was pre-determined and 
concealed 
 
Incomplete 
outcome data 
(attrition bias) 
All outcomes 
Low risk Dropout was not reported but Ns provided in 
Results imply all randomised participants 
were included so one can assume there was 
no dropout 
 
Selective 
reporting 
(reporting bias) 
Unclear risk No protocol. Cluster/composite scores 
presented (means and SDs) for each group 
 
Blinding of 
participants and 
personnel 
(performance 
bias) 
All outcomes 
 
High risk Participants and personnel would have been 
aware of their group assignment 
Blinding of 
outcome 
assessment 
(detection bias) 
All outcomes 
 
Unclear risk Not reported whether outcome assessors 
were blind 
Other bias Low risk None identified 
 
  
141 
 
Appendix 3. Study Information Sheet 
142 
 
 
 
 
143 
 
 
 
 
 
 
 
 
144 
 
Appendix 4. Study Screening Script  
 
STUDY TITLE: An investigation of prospective memory and 
future thinking in cannabis use.  
Protocol ID: 5402/001 
 
Telephone Pre-Screening  
 
Date……………………………………………. 
Screening number……………………………. 
Estimated time: 10 minutes  
Have you read the information sheet about the study and are you interested 
in taking part? 
□ YES 
□ NO (If NO then END) 
 
If cannabis users: 
Please inform volunteers that as part of this telephone pre-screening they will 
be asked some detailed and sensitive questions about their cannabis use to 
determine if they are eligible for the trial, and that if they feel uncomfortable 
about answering any of the questions they have the option not to answer. 
If controls: 
Please inform volunteers that as part of this telephone pre-screening they will 
be asked some detailed and sensitive questions to determine if they are 
eligible for the trial, and that if they feel uncomfortable about answering any 
of the questions they have the option not to answer. 
Volunteer informed: 
□ YES 
□ NO (If NO then END) 
 
Age:  
Date of Birth:  
 
Gender:     Male     /     Female    (circle) 
 
What is your highest level of education? 
□ GCSE 
□ A Level 
□ Vocational training course 
□ Undergraduate degree 
□ Postgraduate degree 
□ Doctorate 
□ Other ………………………………………….. 
 
We’re now going to ask a few questions about your cannabis use.  
 
Do you smoke cannabis? 
□ YES 
□ NO 
145 
 
 
At what age did you start smoking cannabis? 
……………………………………………………. 
 
How many days a week do you smoke? 
□ 1 
□ 2 
□ 3 
□ 4 
□ 5 
□ 6 
□ 7 
 
How many grams do you individually smoke a week? 
……………………………………………………. 
 
How long does it take you to individually smoke an “eighth” (i.e. an eighth of 
an ounce or 3.5 grams)?  
……………………………………………………. 
 
SDS 
We’re now going to ask a few more questions about your cannabis use and 
give a few options to answer. 
 
1. Did you ever think your use of cannabis was out of control?  
□ a. Never or almost never (0 points)  
□ b. Sometimes (1 point)  
□ c. Often (2 points)  
□ d. Always or nearly always (3 points) 
 
2. Did the prospect of missing a smoke make you very anxious or worried?  
□ a. Never or almost never (0 points)  
□ b. Sometimes (1 point) 
□ c. Often (2 points)  
□ d. Always or nearly always (3 points) 
 
3. Did you worry about your use of cannabis?  
□ a. Not at all (0 points) 
□ b. A little (1 point) 
□ c. Quite a lot (2 points) 
□ d. A great deal (3 points) 
 
4. Did you wish you could stop?  
□ a. Never or almost never (0 points)  
□ b. Sometimes (1 point)  
□ c. Often (2 points) 
□ d. Always or nearly always (3 points) 
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5. How difficult would you find it to stop or go without?  
□ a. Not difficult (0 points) 
□ b. Quite difficult (1 point) 
□ c. Very difficult (2 points) 
□ d. Impossible (3 points) 
Add up the points 
SDS score                          / 15 
 
Thanks for that. We are now going to ask you a few more questions.  
Do you drink alcohol?  
□ YES 
□ NO 
 
If YES, at what age did you start drinking alcohol?  
15 
 
If YES, how many days a week?  
□ 1 
□ 2 
□ 3 
□ 4 
□ 5 
□ 6 
□ 7 
 
Please give us an estimate of how much* alcohol you drink a week. Give 
your answer in terms of type and number of drinks consumed. For example, 
five pints of lager and a large glass of white wine.   
2 units . 
 
*21 units woman, 28 units man as broad upper limits for the study 
 
Do you use any illicit (illegal) drugs other than cannabis?  
□ Any illicit drug  
□ No illicit drug used  
If ANY illicit drug  
Drug How often* 
   
  
  
  
  
*Find out if they do it more or less than twice a month 
 
Have you ever been diagnosed/concerned about dependency on any illicit 
substance other than cannabis or nicotine? 
□ YES 
□ NO 
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If YES Provide details  
_____________________________________________________________
_____________________________________________________________
_____________________________________________________________
____________________________________ 
 
Are you fluent in English? 
□ YES 
□ NO (if NO then END) 
 
Are you currently receiving psychiatric medication and/or therapy for a mental 
health problem?  
 
□ YES 
□ NO 
 
If YES Provide details  
_____________________________________________________________
_____________________________________________________________
_____________________________________________________________
____________________________________ 
 
Have you ever been diagnosed with a psychotic disorder (e.g. Schizophrenia, 
Bipolar) or experienced a psychotic episode in the past?  
□ YES 
Provide details (diagnosis, time elapsed since last episode)  
_____________________________________________________________
_____________________________________________________________
________________________ 
□ NO 
 
Have you ever been diagnosed with a learning difficulty? 
□ YES (If YES then END) 
□ NO 
 
Are you currently using any other prescribed medication?  
□ YES  
□ NO 
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If yes, list them here: 
_____________________________________________________________
_____________________________________________________________
_____________________________________________________________
____________________________________ 
Would you be willing to refrain from using drugs/alcohol on the day of the 
testing session?  
□ YES  
□ NO 
 
Thank you for answering these questions. We will let you know if you meet 
criteria for the study very soon. If you do, would you be willing to come to 
UCL for a testing session which will take approximately 2.5 hours? We are 
based by Goodge Street, just off Tottenham Court Road.  
 
Would you be happy for your contact details to be passed on to other UCL 
researcher’s within our group who are currently running studies for which you 
may be eligible to participate? 
□ YES 
□ NO 
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Appendix 5. The Virtual Week Tasks 
 
 
Task type 
 
Monday Tuesday Wednesday Thursday 
Regular event-based tasks 
Take antibiotics at breakfast Take antibiotics at breakfast Take antibiotics at breakfast 
Take antibiotics at breakfast 
 
 
 
Take antibiotics at dinner 
 
Take antibiotics at dinner 
Take antibiotics at dinner 
 
Take antibiotics at dinner 
 
Regular time-based tasks 
Use asthma inhaler at 11:00 
Use asthma inhaler at 11:00 Use asthma inhaler at 11:00 Use asthma inhaler at 11:00 
 
 
Use asthma inhaler at 21:00 
Use asthma inhaler at 21:00 Use asthma inhaler at 21:00 Use asthma inhaler at 21:00 
 
Irregular event-based tasks Pick up your sister's 
membership pass whilst at the 
swimming pool/sports club 
 
Drop in the dry cleaning 
when you go out shopping 
Invite your friend David to 
dinner when you see him 
Ask Jill for the book she 
borrowed when you have 
afternoon tea with Jill 
 Tell Kate that Margaret has 
had a baby girl next time you 
talk to Kate 
 
Return library book borrowed 
by Brian when you are at the 
library 
Buy some stationary supplies 
when you are at the corner 
shop later today 
When you go to use the 
washing machine, set it to a 
gentle cycle 
Irregular time-based tasks 
Haircut at 13:00 
Phone bank at 12:00 to 
arrange an appointment 
 
Meet your friend Michael for 
coffee at 16:00 
 
Submit a report at 15:00 
  
Appointment at library for 
help with computers 15:00 
 
Put casserole in the oven at 
17:00 
Phone David’s sister at 18:00 
about baby sitting 
 
 
Have an x-ray at 16:00 
Appendix 6. Declaration of Joint Research Project 
 
This major research project was a jointly carried out with Samantha Mansell, 
a fellow DClinPsy trainee. The following stages were completed together: finalising 
the study protocol, recruiting participants, and testing participants. We also had help 
in the recruitment and testing phase from Jon Waldron, a Research Methods in 
Psychology MSc student at UCL. We each tested approximately a third of participants. 
 Jon wrote up a subset of the complete dataset for his MSc dissertation (N = 34; 
17 control participants and 17 dependent frequent cannabis users) on the episodic 
simulation of future events (ESoFE) task (participant-ratings only), which is not 
reported in this paper.  Samantha’s thesis reports on the ESoFE task with the full 
sample, considering both the researcher and participant ratings.  
 All three reports include the analyses of baseline demographic data, 
neuropsychogical measures (episodic memory and fluency tasks), depression, anxiety 
and schizotypy.  
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Appendix 8. Consent Form 
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Appendix 9. Virtual Week Script 
 
General introduction before commencing trial day: 
 “VW is a board game played on the computer. The game is about the day-to-
day activities of a typical week and it will ask you to remember lots of tasks 
and ‘perform’ them in the game. You don’t perform them in real life, just in 
the game.” 
 “One circuit of the board represents one virtual day. Your position is 
represented by this blue token. As the token moves clockwise around the board, 
you are going through your virtual day. Try to imagine that each event like it’s 
really happening” 
 “We will start with a trial day, which will introduce you to the features of the 
game. Then you will play 3 virtual days on your own.” 
After beginning, point out the board in the centre where important messages are shown 
and let the participant know to read this when requiring instruction. 
 “Please read aloud all instructions, events and tasks as you move round trial 
day.” 
After the second Help Message, make sure the participant understands the help 
messages, read them aloud. Point out how the time is changing as they move around 
the board. 
After the third Help Message, let the participant know that the token turns dark blue 
when on the correct square. If they miscount and move incorrectly, the game won’t let 
them proceed until they’ve landed on the correct square.  
 
At the first Event Card (Breakfast): 
 “Please read title and all contents of the event cards out loud.” 
Clarify that they need to make a choice about the event, and that they need an 
odd/even/any number to continue moving around the board. Some participants need 
to be encouraged to make a choice for the sake of the game, even if it isn’t what they 
would do in normal life. 
At the first Task Card (antibiotics): 
Explain how the task is related to the Breakfast event card. 
 “So, we must take our antibiotics at breakfast and dinner. If we look back to 
the event card we selected, it tells us we are currently having breakfast. That 
means we have to perform this first task right now.” 
At the second Task Card (asthma inhaler): 
 “These 2 tasks will become your regular tasks for the next two days of the 
game, after this trial day, so you will need to remember them” 
When back to game board, point out the Perform Task button on the board, so that 
participant knows where to find it later for the time-based task. 
Near 11:00 AM. Explain that time-based tasks can still be performed correctly after 
the exact time: 
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 “The game takes into consideration that dice rolls are random, so the token 
won't always land on the exact time. So if a large dice roll takes you past the 
exact time when a task is due, and you perform it immediately, it is still 
considered on time.” 
After trial day is complete: 
 “Ok now that the trial day is over, you will do four virtual days on your own- 
I can’t assist you with remembering the tasks but I am here if you have other 
questions about the program” 
Make sure participant understands the instruction slides before day 1 – explain the 
key points: 
 They must continue to read aloud all task and events, including the title 
 Perform Task button – board and events  
 Make sure you always read aloud the title of event cards 
 You will be getting a break after two days 
 When asked to make decisions on events – try and pick options you would 
choose in real life as it will make the task check easier 
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Appendix 10. Study Results Summary for Participants  
 
 
